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ABSTRACT 
Mesothelium-derived progenitors have been demonstrated to contribute to 
differentiated mesenchymal components of the heart, liver, and gut during 
organogenesis. The precise contribution of the mesothelium to lung 
development, however, has not been fully clarified and the key signals regulating 
mesothelial cell entry have not been identified. 
To rigorously address this issue, we employed mic.ewith an inducible Cre 
expressed from the Wilm's tumor-1 (WT1) locus for high fidelity lineage tracing 
after confirming that Cre-recombinase was mesothelial-specific and faithfully 
recapitulated endogenous WT1 gene expression. We visualized WT1 + 
mesothelial cell entry into the fetal lung by live imaging and identified their 
progenies in subpopulations of bronchial smooth muscle cells, vascular smooth 
muscle cells, and desmin+ fibroblasts by lineage tagging. 
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In view of the role of Sonic Hedgehog (Hh) signaling in regulating 
mesenchymal cell differentiation and epithelial-mesenchymal transition, we 
hypothesized that this pathway regulates events associated with migration of 
mesothelial cells into the developing lung. To examine for this, we first used two 
independent reporter mice to show that Hh signaling is active within the lung 
mesothelium at time points coinciding with the appearance of mesothelium-
derived cells in the lung parenchyma. Using loss-of-function assays in organ 
cultures, and targeted mesothelial-restricted loss-of hedgehog function mice, we 
demonstrated that mesothelial cell movement into the lung requires the direct 
action of Hh signaling . 
In order to examine whether WT1 interacts with Hh pathway, we 
conducted ChiP assays on fetal lung mesothelial cells, and found that WT1 
directly binds and regulates promoter elements of downstream targets of Hh 
pathway. Consistent with this observation, Hh pathway gene expression was 
down-regulated in isolated WT1 deficient fetal lung mesothelial cells. 
Taken together, these findings lend further support to a paradigm in which 
mesothelial cells are an important source of progenitors for mesenchymal 
structures. Our findings also reveal a role for Hh pathway in the early events 
associated with mesothelial cell entry and indicate that WT1 likely acts upstream 
of Hh signaling. 
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PREFACE 
This dissertation is original work, unpublished and conducted independently by 
the author Radhika Dixit, under the guidance of Dr. Alan Fine and Dr. Xingbin Ai. 
This work identifies mesothelial cells as a lung mesenchymal progenitor and 
identifies for the first time the role of hedgehog signaling in mesothelial cell entry 
into the lung (chapter 4.1 ). Further, the significance of WT1 in lung development 
has been examined in chapter 4.2. 
The introduction chapters have been written in a mini review style format and the 
results have been divided into two chapters and each has been formatted as 
research articles. Overview chapter connects the introduction and results section 
and presents a cartoon that describes my PhD thesis work (chapter 2). The last 
two chapters signify the relevance of this study to lung diseases and injury repair 
and remodeling (chapters 5 and 6). 
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Chapter 1 INTRODUCTION 
1.1 Mesenchymal cells in lung development and disease 
1.1.1 Summary 
Mesenchymal tissues in all organs provide structural support and regulate 
movement of cells and soluble factors. Loss or malfunction of discrete 
mesenchymal cells · commonly occurs in debilitating diseases such as 
emphysema, fibrosis, and asthma (reviewed by Horowitz et al., 2012) for which, 
a cure remains elusive. Therefore, knowledge regarding the origin of 
mesenchymal progenitors will help develop novel therapies and facilitate 
treatment. This chapter presents an overview of the various types of 
mesenchymal cells in the lung, their origin, and role in injury-associated 
remodeling process. 
1.1.2 Introduction 
In most species, lung development encompasses prenatal and postnatal life. 
occurs in two phases, structural growth during gestation, followed later by 
functional maturation in post-natal and adult stages. During embryonic 
development, which entails active growth, mesenchymal cells interact with the 
epithelium to regulate budding morphogenesis (Bellusci et al., 1997). By contrast, 
the adult lung is quiescent under homeostatic condition. However, in response to 
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cellular injury caused by physical and chemical agents, mesenchymal cells are 
recruited to the injured area, where they infiltrate and secrete soluble factors, 
essential to initiate remodeling of the injured tissue (Desmouliere et al. , 2005). 
Defects in this process can lead to chronic inflammation and fibrosis. In addition, 
imbalance in mesenchymal cell proportion is associated with asthma, chronic 
bronchitis , and emphysema(reviwed by Horowitz et al., 2012; Wang et al., 2008; 
Rocket al. , 2011 ). In view of the significant contribution of mesenchymal cells in 
lung disease, it is essential to investigate the origin of these cells . This chapter 
does not attempt to provide an exhaustive detail of all the mesenchymal cells and 
lung defects, but rather raises a number of unanswered questions that needs 
further research. 
1.1.3 Mesenchymal cell types 
Classic mesenchymal cells in the lung include a diverse population of fibroblasts, 
smooth muscle cells, cartilage, lipofibroblasts, endothelial cells, and pericytes 
(Fig. 1 ). The adult lung is composed of 25% endothelium, 25% epithelium, 35% 
interstitium, and 15% collagen fibers (Crapo et al., 1982). The loosely packed 
mesenchymal cells are suspended in a network of extracellular matrix (ECM) that 
includes collagen, laminin, elastin , fibronectin, and heparan sulfate. 
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Location of mesenchymal cells 
Mesenchymal cells are located around airways, vasculature and they are 
interspersed throughout the lung parenchyma . They surround and interact with 
different cell types, to perform distinct roles. Below are the different types of 
mesenchymal cells located in the lung. 
Mesenchymal cells around airways: 
Smooth muscle cells, cartilage, and fibroblasts form a sheath around airways and 
anchor them to the surrounding lung parenchyma (Fraser 2005). These cells aid 
in expansion and contraction of the airways (Widdicombe et al., 1963). 
Smooth muscle cells: Smooth muscle are involuntary muscles that are found in 
the lungs, heart, skin , gastrointestinal tract, and urogenital organs. They are 
loosely packed bundles that are arranged either longitudinally or circularly and 
this allows them to contract and relax. 
Smooth muscle cells exist at three different locations in a lung, airway and 
vascular wall, and alveolar septum (Fraser 2005). Airway smooth muscle cells 
(ASM) are derived from FGF1 0+ (fibroblast growth factor 1 0) distal lung 
mesenchymal progenitors and from proximal lung mesenchyme, around mouse 
embryonic day 11.5 (Mailleux et al., 2005; Jesudason et al., 2005). They express 
alpha smooth muscle actin (a-SMA), a smooth muscle structural gene that is 
involved in cell contraction (Ronnov-Jessen et al., 1996) The mechanical force 
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generated by airway smooth muscle cell is crucial to regulate lung growth and 
budding morphogenesis (Jesudason et al., 2005). In addition to contraction and 
relaxation, ASM secretes immunomodulatory cytokines, chemokines, proteases, 
and matrix proteins, and play a role in allergic-inflammatory process in asthma 
(Lazaar et al., 1994; Lazaar et al., 1998; Hirst et al., 2000). 
Cartilage: Cartilage surrounds trachea, mainstem bronchi, lobar bronchi and less 
prominent around bronchioles. Lack of cartilage in the lungs is associated with a 
rare disease called congenital lobar emphysema (Warner at el., 1982). 
Fibroblasts and myofibroblasts: Fibroblasts are found adjacent to smooth muscle 
cells around the airways, and are freely interspersed in the lung parenchyma. 
Although there are no specific markers of myofibroblasts, they express desmin 
and vimentin and are a-SMA positive whereas fibroblasts are SMA negative. 
Fibroblasts secrete ECM proteins and growth factors and are involved in the 
pathogenesis of many lung diseases (Bostrom et al., 1996). 
Mesenchymal cells surrounding vasculature 
Endothelium, vascular smooth muscle cells, and pericytes form blood vessel 
wall. These cells are required for pulmonary circulation and defects can lead to 
pulmonary hypertension. 
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Endothelial cells: They have leaky junctions, required for the exchange of water, 
solutes, and various molecules across capillaries and interstitium (Renkin 1992). 
Platelet endothelial cell adhesion molecule (PECAM-1) also known as cluster of 
differentiation 31 (CD31) is a protein that is expressed in endothelial cells and 
some immune cells (Delisser et al., 1993). Chondroitin sulfate or NG-2 is a 
proteoglycan that is expressed in pericytes and endothelial cells (Piuschke et al., 
1996). 
Vascular smooth muscle: Smooth muscle around the arteries and ve1ns are 
called vascular smooth muscle cells (VSM). They develop late in gestation 
compared to ASM (Ghosh et al., 2011). Both these cell types have a similar 
morphology and express a-SMA. However, recent studies have indicated that 
there is a difference between ASM and VSM. Notch-3 , one of the receptors of 
the notch-signaling pathway is selectively expressed only in VSM and not ASM 
(Ghosh et al., 2011 ). Remarkably, Notch-3 activation occurs from late gestation 
until post-natal stage, a crucial time when the lung vascular system is switching 
from a low-pressure state to a high-pressure state, immediately after birth 
(Ghosh et al., 2011, Gao et al., 2010), further emphasizing the role of VSM in 
maintaining normal blood pressure. 
Adventitia: Adventitia is a layer of vessel wall composed of fibroblasts , 
connective tissue, neNes, lymphatic vessels, and immune cells such as 
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macrophages, T-cells and 8-cells. Adventitia controls lumen size by regulating 
vascular smooth muscle tone. Adventitial layer functions as stem cell niche for 
endothelial and mural progenitor cells and participates in growth and repair of the 
vessel wall (reviewed by Majesky et al. , 2011) . 
Mesenchymal cells in the interstitium 
Myofibroblasts are interspersed in the lung parenchyma. They secrete 
extracellular matrix proteins including collagen I, cytokines and growth factors , 
required for lung repair and remodeling post-injury (Hinz et al., 2007). There is 
considerable controversy regarding the origin of myofibroblasts, since there are 
no markers to indicate that this is a distinct cell type. Bostrom et al. , (1996) 
identified that Pdgf-A+ epithelial cells, give rise to alveolar myofibroblasts that are 
desmin positive and a-SMA negative. However, other groups have identified 
myofibroblasts that express both these markers (Zhang et al. , 1994). Other 
mesenchymal cells such as lipofibroblasts are also found in the interstitium. and 
their role and origin has not been identified . Notably, Fibrocytes or circulating 
cells are another group of mesenchymal cells that are bone marrow-derived and 
uniquely express markers of hematopoietic progenitors, fibroblasts, and 
chemokine receptors. They participate in tissue remodeling by secreting ECM 
proteins and also differentiate into fibroblasts and myofibroblasts, as well as 
adipocytes (reviewed by Strieter et al. , 2009). 
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Extracellular matrix components 
In an embryonic lung, basement membrane, collagen and ECM molecules such 
as laminin , fibronectin , and proteoglycans play important roles in branching 
morphogenesis. In a neonatal and adult lung , ECM molecules that form a tight 
barrier to the diffusion of macromolecules between the fibroblasts and epithelial 
cells undergo damage following injury, thereby triggering an immune response 
that in turn starts a repair process. Disruption of this communication is associated 
with airway remodeling and disease (McGowan et al. , 1992). ECM proteins arise 
from multiple cell types including pleural mesothelial cells (Nasreen et al. , 2009; 
Milligan et al., 1995). 
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Figure 1: Cartoon depicting the types of mesenchymal cells in the lung 
~ BSM 
~ VSM 
GJ Endothelial cell 
Q Type I cell 
EJ Epithelial cell 
~;,7 Adventitia 
< i/ Type II cell 
~ Lipofibroblast 
~ Myofibroblast 
<0 Pericyte 
Note: Type I and Type II and mesothelial cells are epithelial and not 
mesenchymal cells. BV- blood vessel, blue line- (mesothelial cells) lung surface 
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1.1.4 Origin of mesenchymal cells 
There is much debate regarding the origin of mesenchymal cells in the lung. 
Majority of the studies indicate that mesenchymal cells arise from mesoderm, 
one of the three germ layers. However; neural crest cells from the embryonic 
ectoderm (Jiang et al., 2000) and multiple other cell types including epithelial 
cells and bone marrow stem cells, also to contribute to lung mesenchyme. Table 
1 gives an overview of the different types of lung mesenchymal cells and their 
source of progenitors. 
Clonal analytic studies using mouse models have given clues to the 
source of the mesenchymal cell types arising in the lung. Table 1 shows that the 
markers used to generate tools for lineage analysis are not specific to a single 
progenitor cell type. Moreover, multiple progenitors differentiate to give rise to the 
same mesenchymal cell, raising questions about the specificity of these studies. 
Some issues that need to be addressed in the future: 1) Are there intrinsic 
differences between mesenchymal cells arising from different origin? 2) Are there 
subtypes of a specific mesenchymal cell? 3) Does a mesenchymal subtype 
localize to specific area within the lung? 4) Do certain types of mesenchymal 
cells exist under normal homeostatic condition and another subtype that gets 
upregulated in injury and disease process or vice versa in a repair and 
remodeling process? 5) How do mesenchymal cells renew overtime? This 
question is an important one to address since, if the cells undergo apoptosis after 
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injury, knowledge regarding the origin of the cells can be useful to develop 
potentially new therapies to cure diseases and not just treat it from time to time. 
In order to address these questions, it is essential to gain a better 
understanding of the origin of mesenchymal cells in the lung and this in turn will 
help obtain important insights into pathologic responses of lung mesenchymal 
cells to environmental cues. 
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Table 1 Mesenchymal cells in the lung parenchyma 
Mesenchymal Cell Progenitor cell of Mouse Strain References Location, markers Origin 
Primitive lung Dermo1 cre Yu et al. , 2003 
mesenchyme 
Airway smooth muscle Pdgf-A+ epithelial Pdgfa_1_ Bostrom et al. , 1996 cells- localized to cells Lindah I et al., 1997 
cartilaginous main stem 
bronchi and airways (a- FGF-10-Iung Fgf-1d-acZ Mailleux et al. , 2005 
SMA+ and desmin+) mesenchyme 
CD44+ multipotent Circulating Klein et al. , 2011 
stem cell MSC- in vitro 
Primitive lung Tbx-4CreER Greif et al. , 2012 
mesenchyme Dermo1"re Yu et al. , 2003 
Vascular smooth muscle Secondary heart Tbx1cre Maeda et al. , 2006 cells - localized around field 
endothelial cells of arteries Wnt7b, epithelium Wnt7b1acZ-t- Shu et al. , 2002 
and arterioles (a-SMA and Jiang et al. , 2000 desmin, Notch-3, NG-2, Neural Crest cells Wnt1 cre 
Pdgfra) Nakamura et al. , 2006 WT1Cre Que et al. , 2008 
Mesothelial cells MesothelincreER Rinkevich et al. , 2012 
Venous smooth muscle 
cells - localized around Pulmonary 
endothelial cells of veins (a- Neuroendocrine CGRPCreER Song et al. , 2012 
SMA, Notch-3, NG-2, cell 
Pdgfra) 
Pericytes around Primitive lung Dermo1cre Yu et al. , 2003 
endothelial cells of blood mesenchyme 
vessels and alveolar septal Pdgf-A+ epithelial Pdgfa_1_ (Pdgfrl3, desmin, NG-2 Bostrom et al., 1996 
chondroitin sulfate) cells 
Endothelial cells- line all Tie2, endothelial the blood vessels in the lung Tie2cre Braren et al. , 2006 
(Pecam 1, Tie1) cells 
Myofibroblast -localized in Dermo1 Dermo1cre Yu et al. , 2003 
lung parenchyma and 
around airways (desmin+, a-
Pdgf-A+ epithelium Pdgfa_1_ Bostrom et al. , 1996 
SMA-) Fsp1- mesenchyme Fsp1 cre Trimboli et al. , 2008 
Cartilage - localized to Sox9- epithelium Sox9_1_ Ikeda et al. , 2005 
main stem bronchi around 
large airways (Sox9, Col12a1- Co/12a1cre Ovchinnikov et al. , Collagen 2a1 , alcian blue) mesenchyme 2000 
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1.1.5 Role of mesenchymal cells in disease 
Adult lung is the only vital organ that is directly exposed and affected by the 
outside environment. In response to injury, wound healing program is swiftly 
initiated which leads to alterations in mesenchymal cells. Defects in this process 
can lead to a variety of lung diseases including asthma, chronic obstructive 
pulmonary disease (COPD), pulmonary fibrosis, hypertension, and emphysema 
(reviwed by Horowitz et al. , 2012; Wang et al. , 2008; Rocket al. , 2011). Chronic 
lung diseases are the third leading cause of death worldwide and create a global 
health problem (Barnes 2008; Ley et al. , 2011). Current treatment strategies only 
alleviate symptoms, and so far, effective causal therapies have not been 
developed. Despite intense efforts , the underlying pathogenesis of the disease 
and the mechanism that contributes to repair and remodeling process remains 
elusive. 
Asthma: Asthma is a chronic disease characterized by intermittent narrowing of 
airways and excess mucous production , leading to discomfort in breathing . It 
affects over 24 million people in the United States (Moorman et al. , 2007). Airway 
obstruction is mediated by bronchial smooth muscle hyperplasia and hypertrophy 
leading to airway hyper-responsiveness, airflow limitation, and airway wall 
inflammation. Structural changes of airways include fibronectin deposition , 
collagen Ill and IV deposition , basement membrane thickness, goblet cell 
hyperplasia, and increase in airway smooth muscle mass and size (Jeffery, 2001; 
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James et al., 2002; James et al., 2012). Smooth muscle cells are integral to the 
pathophysiology of asthma. They reduce the luminal diameter of the airways as it 
contracts and resists relaxation. ASM also secretes pro-inflammatory cytokines 
such as IL-6, IL-13, IL 17, and TGF-~ (reviewed by Xia et al., 2013). 
Asthma affects small and large airways. Small airways have an internal?? 
diameter of less than 2mm in humans (Solbert Permutt et al., 2007; Carroll et al., 
1993; Permutt 2007; Canning, 2006; Ebina et al., 1993). Extreme cases of 
asthma can lead to morbidity and mortality of a patient. Comparison of fatal and 
nonfatal asthmatic lung samples have given clues to the pathologic description of 
severe and mild form of asthma. Fatal asthmatics have more number of smaller 
airways with smooth muscle hyperplasia (Sa etta et al., 1991 ). Severe asthmatics 
have a 2-3 fold increase in smooth muscle content around cartilaginous airways 
and less around medium-sized membranous airways (Carroll et al., 1993; 
Benayoun et al., 2003). Taken together, these data indicate that substantially 
different mechanisms underlie the process of small airway and large airways in 
disease. 
In order to develop drugs that target only small airways versus 
cartilaginous airways, it is essential to address these questions: 1) what is the 
origin of smooth muscle around small airways. 2) Are membranous, small, and 
cartilaginous ASM derived from one a single progenitor or different progenitors? 
3) Are proximal and distal ASM derived from unique progenitors? 4) Is there is a 
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selective response of these cells to unique environmental cues. 5) Is there a 
genetic difference in the smooth muscle of chronic asthmatics versus fatal 
asthmatics? 
Pulmonary Hypertension: Pulmonary hypertension is high blood pressure in 
the arteries going to the lung (http://www.thoracic.org) . It is caused by hyper-
proliferation of vascular smooth muscle cells , endothelial cells and fibroblasts 
leading to thickening of the media around the arteries (reviewed by Sakao et al. , 
201 0) . If not treated , pulmonary hypertension, a serious illness, can become 
fatal. 
Broncho-Pulmonary Dysplasia (BPD): BPD is a chronic disease that usually 
occurs in children born prematurely. BPD is caused by exposure to high oxygen 
through mechanical ventilation, leading to inflammation and alveolar septum 
injury. BPD also causes increased bronchial smooth muscle and myofibroblast 
content leading to impaired lung development. (Bland , 2005; Hershenson et al., 
1997). In rare cases, BPD is seen in children with inactivating mutation of Wilm's 
tumor-1 (WT1 ), a gene that is specifically expressed in mesothelial cells 
(Dharnidharka et al. , 2001 ). 
Pulmonary Fibrosis: Pulmonary fibrosis (PF) describes a group of lung 
diseases in which thickening of the walls of the air sacs (called alveoli), caused 
by scarring, can result in cough, shortness of breath, fatigue and low blood 
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oxygen levels (http://www.thoracic.org) . This leads to matrix deposition, 
excessive myofibroblasts production, loss of basement membrane triggering 
fibrotic lesion and scarring of the lung (Ohta et al. , 1995; Zhang et al., 1996; 
Thannickal et al., 2004). Fibroblasts and myofibroblasts play essential roles in 
pathological process of this disease, by secreting growth factors as well as 
collagen and other matrix proteins. Fibrosis usually resolves overtime, however, 
in idiopathic pulmonary fibrosis (IPF), the natural healing process is defective, 
leading to prolonged and excessive production of myofibroblasts, ultimately 
leading to death within 5 years from the time of detection. The origin of 
deregulated and excess myofibroblast in IPF is known, although, it has long been 
speculated that pleural mesothelial cells contribute to the pathogenesis of this 
disease ( Decologne et al., 201 0; Mubarak et al., 2012). Till date, this theory has 
not been proved. 
Emphysema: Emphysema, another component of chronic airflow obstruction 
(COPD) , entails the destruction of alveoli (air sacs) in the lungs, impairing their 
ability to bring oxygen into the body and eliminate carbon dioxide 
(http://www.thoracic.org). Emphysema is a complex disease characterized by 
inflammation and destruction of alveolar epithelial cells (airspace enlargement), 
apoptosis of lung epithelium, endothelium, and interstitial mesenchymal cells. 
Ultimately, emphysema occurs due to excessive myofibroblast activation and 
impaired mesenchymal cell reparative process (reviewed by Horowitz et al. , 
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2009). The condition of patients suffering from emphysema worsens over time in 
spite of cessation of smoking. There have been reports indicating that the 
fibroblasts in emphysema have a reduced proliferative capacity when compared 
to fibroblasts in normal lung (Baglole et al., 2006). These data suggest that there 
might be two unique sets of fibroblast population in the lung, one contributing to 
pathologic scar formation and the other required for wound repair. Future lineage 
studies will need to address this issue. 
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1.1.6 Perspective 
Gaps in our understanding of lung mesenchyme biology can potentially be 
overcome, by conducting a thorough lineage analysis. In the future, markers 
used to develop mouse genetic tools for lineage tracing , must first be 
systematically characterized, to confirm that the gene is selectively expressed 
only in one cell type within an organ . Clonal analytic studies could help clarify the 
location and contribution of individual mesenchymal cells during lung 
development and disease. In addition, new source of mesenchymal progenitors, 
such as mesothelial cells should be characterized, and their role in chronic lung 
diseases identfied. 
The next chapter will discuss the role of mesothelial cells in lung 
development, particularly lung mesenchyme. 
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1.2 Mesothelial cells 
1.2.1 Summary 
Mesothelial cells have recently been shown to be a source of progenitors for 
differentiated mesenchymal cells (Wilmet al. , 2005; Que et al. , 2008; Zhou et al. , 
2008 ). However, the potential role of mesothelium in lung development has not 
been fully clarified . This chapter reviews current knowledge on mesothelial cell 
structure and function , and role of mesothelial progenitors in embryonic 
development. 
1.2.2 Introduction 
The term mesothelium was coined by Minot in 1880, where he observed 
"epithelial lining of mammalian mesodermic cavities"(reviewed by Mutsaers 
2002) . Mesothelial cells are a monolayer of squamous epithelial cells that 
surround the three serosal cavities pleura, pericardium and peritoneum and also 
line the organs within the abdominal and thoracic cavities (Fig. 2A). 
1.2.3 Structure of mesothelial cells 
Mesothelial cells are 25 J.lm in diameter, with a central round nucleus surrounded 
by a thin cytoplasm (Slater et al. , 1989). The luminal surface of a mesothelium 
has a well-developed microvilli with an occasional primary cilium (Fig. 28). The 
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cells are closely packed and are joined by tight junctions and desmosomes. They 
are supported by basement membrane and connective tissue fibers that aid in 
epithelial-mesenchymal transition and migration of mesothelium into the injured 
tissue (Mutsaers 2002). 
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Figure 2: Location of mesothelial cells 
A B 
(A) Red dashed lined mesothelial cells are seen surrounding internal organs in 
the abdominal and thoracic cavities (lungs and heart) , yellow line- diaphragm. (B) 
Pleura composed of red mesothelial cells with primary cilia resting on basement 
membrane and connective tissue fibers. 
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1.2.4 Mesothelial cells in multiple organs 
Morphologically, mesothelial cells are thin and squamous-like in most anatomical 
sites, except septal folds of pleura and peritoneal side of diaphragm, where they 
are cuboidal. A genome wide profile study compared visceral and parietal pleura 
and found intrinsic genetic differences between these cell types (Roe et al., 
2009), potentially suggesting distinctive response to environmental factors. 
1.2.5 Multiple Functions of Mesothelial Cells 
1) Mesothelial cells are tightly packed to maintain serosal integrity and protect 
against wear and tear caused by intracoelomic organ movement (Fig 28) 
(Mutsaers 2004). 
2) They facilitate transport of fluid and cells across serosal layer (Mutsaers 
2002) . 
3) Mesothelial cells provide a protective barrier against pathogens by secreting 
surfactant, glycosaminoglycans, predominantly hyaluron and proteoglycans 
(Mutsaers 2002). 
4) Mesothelium is a slow renewing tissue with only 0.16% to 0.5% cells 
undergoing mitosis at one time. However, within 48 hours of the injury, 30-80% of 
mesothelial cells begin to proliferate and synthesize DNA. They release pro-
inflammatory, anti-inflammtory and immunomodulatory mediators including 
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chemokines, cytokines, and growth factors that participate in resolving 
inflammation and tissue repair (Slater et al. , 1989). 
5) Mesothelium is a source of progenitors for differentiated mesenchymal cells in 
multiple organs and contributes to tissue repair after injury. 
1.2.6 Markers of mesothelial cells 
Mesothelial cells express mesenchymal markers such as vimentin and desmin as 
well as characteristic epithelial markers including cytokeratin . Other proteins that 
are expressed in mesothelial cells include wilms tumor1 (Wf1 ), mesothelin, 
MCP130, calretinin , sulfatase1 , uroplakin3B and raldh2. Among these markers, 
wr1 and more recently mesothelin have been used as markers for tracing the 
fate of mesothelial cells in multiple organs including the lungs (Wilm et al., 2005; 
Que et al. , 2008; Zhou et al., 2008; Rinkevich et al., 2012). Notably, mesothelial 
cells lining the adult lung do not express the same markers as the fetal 
mesothelium. 
Wilm's tumor-1 
wr1 is a zinc finger transcription factor that is specifically expressed in visceral 
and parietal mesothelial cells, kidney podocytes and glomerular capillaries 
(Scholz and Kirschner, 2005). Loss of wr1 results in kidney and spleen agenesis 
as well as reduced cardiomyocyte mass and lung malformation (Kreidberg et al. , 
1993; Moore et al. , 1999). In human lungs, bi-allelic WT1 mutations are 
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associated with pulmonary dysplasia and mesothelioma (Dharnidharka et al. , 
2001 ; Loo et al. , 2012) . WT1 controls kidney formation by regulating expression 
of key target genes that include hedgehog (Hh) and Wnt pathway constituents 
(Kreidberg et al., 1993; Hartwig et al., 2010). 
Mesothelin 
Mesothelin is a 40 kDa membrane glycoprotein that is upregulated in 
mesotheliomas, ovarian cancer, pancreatic cancer, and lung adenocarcinoma. 
Mesothelin is expressed in pleura, pericardium and peritoneum. To date, the 
biological function of mesothelin is not known; however, the cleaved fragment 
that is released from the mesothelin transmembrane protein , called the 
megakaryocyte-potentiating factor, is currently being evaluated as a marker for 
tumor diagnosis and as a potential immunotherapeutic agent (Chang et al. , 1996; 
Hassan et al. , 2004) . 
LRRN4 
LRRN4 is Leucine rich repeat neuronal-4 protein that is involved in long-term 
memory formation. It is upregulated in acute lung injury and in chronic obstructive 
pulmonary disease. LRRN4 is expressed in primary mesothelial cells and is 
significantly down regulated in mesotheliomas (Kanamori-Katayama et al., 2011) . 
Uroplakin 38 
Uroplakin 38 is expressed in urothelial cells, retinal pigment cells as well as 
mesothelial cells of the peritoneum, pleura, and pericardium. Uroplakins are cell-
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surface proteins that regulate signal transduction events. The expression of 
uroplakin 38 is significantly downregulated in mesothelioma, suggesting its role 
as a tumor suppressor gene (Kanamori-Katayama et al., 2011 ; Hu et al. , 2002). 
Sulfatase 1 
Sulfatase1 (Sulf1) is a heparan sulfate 6-0-endosulfatase enzyme that removes 
6-0 sulfate groups from heparan sulfate, an extracellular matrix structure. 
Heparan sulfate is an essential regulator of cell signaling pathways. Sulfatase1 
modulates heparan sulfate by regulating its binding partners. In Sertoli cells of 
testes , Sulfatase1 is regulated by WT1 , a master transcription factor. (Langsdorf 
et al., 2011). Indeed both these genes are expressed in mesothelial cells lining 
the lung. 
Raldh2 
Retinaldehyde dehydrogenase 2 or Raldh2 (ALDH1A2 gene) is expressed in 
mesodermal and mesothelial cells. The enzyme produced from this gene 
catalyzes the reaction from retinaldehyde to synthesize retinoic acid. Retinoic 
acid is required for initial stages of embryogenesis and is essential for lung 
development (Desai et al., 2006) . 
Calretinin 
Calretinin is a calcium binding protein required for intracellular calcium migration. 
It is expressed in many tissues including central and peripheral nervous system, 
retina, mesothelium, adipocytes, sertoli cells of testes. It is highly upregulated in 
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several types of cancers including mesotheliomas, and adenocarcinomas 
(Barberis et al. , 1997). 
1.2.7 Role of mesothelial cells in disease processes 
Mesothelioma 
Mesothelioma is a highly malignant tumor that arises from . visceral and parietal 
mesothelium. It is primarily caused by exposure to asbestos although recent 
studies have shown that SV-40 Simian virus could potentially lead to 
mesothelioma. Current standard chemotherapy and radiation are not effective in 
treating mesothelioma, leading to poor prognosis (reviewed by Jaurand and 
Bignon 1993). Hence, it is imperative to study the role of mesothelial cells in lung 
development and cancer. 
Idiopathic Pulmonary Fibrosis 
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and lethal disease of 
unknown etiology. It is characterized by sub-pleural localization of fibrosis 
(excess myofibroblasts) and deposition of extracellular matrix components. It has 
been a long-standing belief that mesothelial cells play a central role not only in 
pleural fibrosis but also in the onset and progression of IPF (Park and Lee 2013) . 
In support of this hypothesis, a recent study demonstrated in vitro differentiation 
of pleural cells to myofibroblasts (reviewed by Zolak et al., 2013). 
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1.2.8 Fate of mesothelial cells in organ development and injury repair 
Mesothelial cells are highly susceptible to damage from air, water, and foreign 
substances. This causes the cells to swell and slough from the surface into the 
fluid-filled pleural space. Evidence of mesothelial cell movement and migration 
comes from studies examining the serosal layer restoration after abdominal 
surgery, where they showed that free-floating mesothelial cells incorporate into 
the wound site and proliferate immediately after injury; however, the source of 
these cells were not identified (Herrick and Mutsaers 2004) . 
Genetic lineage tracing , an extremely powerful tool has given clues to the 
role of WT1 +, mesothelin+ mesothelial cells in coelomic organs. Table 2 lists the 
mouse strain generated to examine the fate of mesothelial cells in coelomic 
organs. Using a mouse that expresses an inducible Cre-recombinase from the 
endogenous WT1 locus (Zhou et al. , 2008), mesothelial cells lining fetal heart, 
gut and liver were shown to migrate inward and contribute to cardiomyocytes , 
vascular smooth muscle, endothelium, hepatic stellate cells, and perivascular 
mesenchyme (Zhou et al. , 2008; Wilmet al. , 2005; Asahina et al. , 2011). 
In the lung, three independent studies using Cre-lox lineage tracing 
system found conflicting results regarding the contribution of fetal lung 
mesothelial progenitors (Que et al., 2008; Greif et al., 2012, Rinkevich et al. , 
2012). The first study used a non-inducible WT1-Cre (WT280Cre YACJ 
transgenic mouse line and showed that mesothelium gives rise to intra-
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pulmonary artery VSMCs (Wilmet al. , 2005; Que et al. , 2008) . These results are 
confounded , however, by uncertainties regarding the strength , timing , and 
specificity of the cellular marking in this transgenic Cre line. The second study, 
which was focused on lineages in the main pulmonary artery, used an inducible 
knock-in WT1 creERT2!+ line and showed that the mesothelium is not a significant 
source of smooth muscle cells for this structure (Greif et al. , 2012). Recently, a 
third study employed a MslncLN mouse that contains an inducible CreERT2 
knocked into the mesothelin gene locus. This study, however, lacks temporal 
delineation of mesothelin expression and correlation with the Cre activity specific 
to the fetal lung mesothelium. Due to caveats of these three previous studies, the 
precise contribution of the early fetal mesothelium to lung development, thus, 
remains an open question. Further, epicardial derived cells were found to also 
contribute to repair of injured heart tissue in the adult by serving as a source of 
new cardiomyocytes (Smart et al., 2011) . Whether analogous mechanisms are 
operative in the developing and mature lung will need to be the focus of future 
studies aimed at treating lung mesenchymal defects. 
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Table 2: List of mouse lines used to lineage trace mesothelial cells 
Mouse Strain 
WT280Cre YAC 
Wilm et al., 2005 
WT1creERT21+ 
Zhou et al., 2008 
WT1GFP-Cre 
Zhou et al. , 2008 
Wt111RES/GFP-Cre 
(WT1 Cre-YFP) 
(Del monte et al., 2011; Wessels et 
al., 2012) 
MslnCLN-CreERT21+ 
(Rinkevich et al. , 2012) 
Targeting cell 
Gut- Vascular smooth muscle (Wilm et 
al., 2005) 
Lung- Vascular smooth muscle (Que et 
al., 2008) 
Heart- smooth muscle cells (Wilm et al. , 
2005) 
Heart- Epicardium, cardiomyocytes, 
vascular smooth muscle cells , 
endothelium (Zhou et al., 2008) 
Liver- Hepatic stellate cells, 
myofibroblasts, perivascular 
mesenchyme (Asahina 2011) 
Broad recombination throughout 
embryo (not an efficient tool to trace 
fate of mesothelial cell in the lung) 
Intestine and gut- Endothelium, smooth 
muscle, visceral musculature, pericytes, 
Cajal cells (Carmona et al., 2013) 
Heart- Parietal leaflets of atrioventricular 
valves (Wessels et al., 2012), coronary 
vessels (Del monte et al., 2011) 
Lung, Intestine, Liver, Gut, Thymus -
visceral mesothelial cells , fibroblasts 
and smooth muscle cells of the 
vasculature in multiple internal organs 
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1.3 Hedgehog signaling in lung development 
1.3.1 Summary 
During development signal transduction pathways work together with 
transcription factors to regulate various cellular events leading to the formation of 
a complex organ . Hedgehog (Hh) pathway is one of the central players that 
control this process (Ingham and McMahon 2001 ). In the lung, Hh signaling 
regulates branching morphogenesis, mesenchymal cell proliferation , and 
differentiation (Bellusci et al., 1997; Pepicelli et al. , 1998). In view of these data, 
we examined the potential role of Hh pathway in lung mesothelial cells. This 
chapter provides an overview of Hh pathway and its role in lung development 
and disease. 
1.3.2 Introduction 
Organ formation involves careful orchestration of many signaling pathways by 
transcription factors including Forkhead box, Nkx homeodomain, and Gli family. 
In the lung, several signal transduction pathways modulate lung epithelial 
branching morphogenesis and regulate smooth muscle cell myogenesis, these 
include soluble factors such as fibroblast growth factors, sonic hedgehog, 
transforming growth factor {3, bone morphogenetic proteins, and retinoic acid. 
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The name hedgehog derives from similarities of the "Hedgehog" mammal, 
to the Drosophila mutant with short and spiked cuticle phenotype. Hedgehog 
family of proteins regulate segment polarity gene to govern axial patterning of the 
embryo (Chiang et al., 1996). In mice, Shh null embryos display multiple organ 
defects including hypoplastic lungs, impaired branching , and lack of smooth 
muscle cells in the lung (Tsukui et al. , 1999). 
1.3.3 Hedgehog Signaling Pathway 
Mammals express three ligands of Hh pathway, Sonic Hedgehog (Shh), Indian 
Hedgehog (lhh) and Desert Hedgehog (Dhh) (reviewed by Varjosalo and Taipale 
2008). Shh is predominantly expressed in epithelia at numerous sites of 
epithelial-mesenchymal interactions including notochord, floorplate of the neural 
tube, tooth , hair, whisker, lung, gut, bladder, urethra, vas deferens, rugae, and 
limbs. Dhh is expressed in Schwann and Sertoli cells whereas lhh is expressed 
in gut and cartilage (Adolphe et al. , 2004; reviewed by Varjosalo and Taipale 
2008). 
The Drosophila Hh gene encodes a precursor protein that is autocleaved 
to release a 19 kDa amino peptide. It is modified post-translationally by the 
addition of glycoproteins, palmitate, and cholesterol residues at the N and C 
terminus. This modification is essential for Hh to migrate across tissue surface. 
The active Hh ligand expressed in epithelial cells signals to its receptor Patched 
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(Pte), a penta-transmembrane protein, in mesenchymal cells. This releases the 
inhibition of Patched on Smoothened (Smo) , a G protein-coupled transmembrane 
spanning receptor into the cytoplasm to activate Cubitus interruptus (Ci) , a 155-
kDa transcription factor (Fig. 3). Ci is further cleaved to form a 75-kDa 
transcription inhibitor. Gli 1, 2, and 3 are zinc-finger transcription factors that are 
vertebrate Ci gene orthologs (reviewed by VanTuyl and Post, 2000) . The active 
form of Gli proteins translocate to the nucleus and bind to shh-responsive 
elements to induce transcription of Hhip (Hedgehog inhibitory protein) , Patched , 
Gli proteins, and other downstream target genes such as insulin-like growth 
factor-2 (IGF-2) , platelet derived growth factor receptor alpha (PDGFR-a) . Gli1 
and Gli2 are activators of Hh pathway whereas Gli3 represses this pathway 
(reviewed by Varjosalo and Taipale 2008). 
Hh pathway is modulated in vitro by a number of small molecule agonists 
and antagonists that directly regulate the Smoothened receptor. Cyclopamine is 
a natural alkaloid produced by the plant Veratrum Ca/ifomicum (Chiang et al., 
1996). It specifically inhibits the Hh pathway by directly binding to the 
Smoothened receptor whereas sonic hedgehog agonist (SAG) is a chemical 
modulator, constitutively activates Hh pathway. These molecules and several 
others are being evaluated as potential therapeutic agents to inhibit cancer 
growth and metastasis (reviewed by Gupta et al. , 2010). 
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Figure 3: Model depicting key players of hedgehog pathway 
SAG cyclopamine 
Mesenchymal cell 
Hedgehog (Hh) ligand binds to the receptor Patched (Pte), a 10-transmembrane 
protein in mesenchymal cell which releases the inhibition of Pte on Smoothened 
(Smo), a ?-transmembrane protein. This activates the Gli family of transcription 
factors; where it translocates into the nucleus and transcribes downstream 
targets. SAG-Sonic hedgehog agonist constitutively activates Hh pathway by 
binding to the receptor Smo. Cyclopamine inhibits Hh pathway. 
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1.3.4 Hh pathway in lung development 
Mammalian foregut primordium gives rise to lungs and proximal gut through 
interactions between endodermal cells and splanchnic mesoderm (Morrisey and 
Hogan 201 0) . There are catalogue of factors that are required for this process. 
Shh signal transduction pathway regulates lung development via interaction with 
transcription factors and growth factors. Furthermost significant association 
required for lung mesenchyme formation and epithelial-mesenchymal transition 
are discussed below. 
In the developing mouse lung, Shh is detected at low levels throughout the 
epithelium, whilst at higher level in the growing distal buds (Bellusci et al. , 1997a; 
Urase et al., 1996). The downstream Hh pathway components , Gli family of 
transcription factors are present in the foregut mesoderm and later expressed in 
the lung mesenchyme (Grindley et al. , 1997). A recent study using a Gli1Lacz 
mouse demonstrated that Gli transcription factors are active in an adult lung (Liu 
et al. , 2013). However, Shh ligand expression was not found in an adult lung 
epithelium. 
Shh null mutation produces lung hypoplasia and failed 
tracheaoesophageal septation whereas partial inactivation causes 
tracheobronchial cartilage abnormalities (Miller et al. , 2004) (See fig. 4) . Mice 
with combined loss of Hh pathway components (Giiz'- and Gli3_1_) do not form 
trachea and lungs (Grindley et al., 1997). The expression of, Pte, Gli1, G/i3, and 
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FGF1 0 is downregulated in Shh knockout lungs (Bellusci et al. , 1997; Litingtung 
et al. , 1998; Pepicelli et al. , 1998). FGF10 is essential for mesenchyme 
formation in the lung. FGF1 0+ mesenchymal progenitors differentiate to smooth 
muscle cells under the control of Shh and Bmp-4, therefore loss of either FGF1 0 
or Shh results in reduced smooth muscle and mesenchyme in the lung. In 
contrast, overexpression of Shh results in hypoplasia and significant increase in 
mesenchymal proliferation in the lung (Bellusci et al., 1997). Hh pathway is 
regulated by multiple feedback loop mechanisms involving Pte, Gli1, Hhip and 
FoxA2, defects in these genes causes accelerated lethality (Chuang and 
McMahon, 1999; Goodrich et al. , 1996). 
In addition , Hh pathway regulates other signaling molecules such as BMP-
4, Vegfa, and Wnt-2 to induce vasculogenesis, mesenchymal cell proliferation , 
and initiate lung growth (Bitgood and McMahon 1995; Astorga and Carlson 2007; 
Lawson et al. , 2002). Fork head box F1 (Foxf1) gene plays a pivotal role in gut 
and lung morphogenesis. It is expressed in the mesodermal cells and is directly 
upregulated by Shh from the lung epithelium (Mahlapuu et al., 2001 ). Shh also 
regulates the expression of the transcription factor Sox9, to induce type II 
collagen (Col2a 1) thereby promoting cartilage formation (Park et al. 201 0) (See 
fig . 4). 
Notably, Fgf9 that is expressed in pleural mesothelial cells coordinates 
with Hh pathway, to regulate development of mesenchymal cells in the lung 
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(White et al. , 2006 ). However, direct interaction of WT1 , a mesothelium specific 
marker with Hh pathway has not been examined in the lung; chapter four will 
examine this issue. 
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Figure 4: Role of Hh signaling in lung development 
A Blood Vessels 
t 
Cartilage ~ Hedgehog~ Branching 
Development Signaling Morphogenesis 
! 
Smooth 
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(A) Depicts various roles of Hh pathway in lung development. (B) Interaction of 
Hh pathway with other signaling molecules to induce lung formation. Foxf1 - Fork 
head box F1, BMP4- Bone morphogenetic protein-4, Vegfa - Vascular 
endothelial growth factor a, FGF1 0- Fibroblast growth factor 10, Wnt2- Wingless 
type-2, Hhip1- Hedgehog inhibitory protein-1. 
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1.3.5 Hh pathway regulates developmental processes 
Hh signaling in proliferation 
Shh regulates proliferation of a number of different cell types including tooth 
(Cobourne et al. , 2001), neural crest cells (Ahlgrenen and Bronner-Fraser 1999) 
and neuron progenitors (Kenney et al., 2003). In the lung, proliferation of 
multipotent mesenchymal progenitors depends on Shh and Wnt7b signaling 
(Morrisey and Hogan 201 0). Hh pathway directly regulates key genes required 
for cell growth and proliferation including cell cycle specific genes CyclinD and 
CyclinE (Knoepfler et al., 2002). In the brain , Shh peptide is secreted into the 
circulating cerebrospinal fluid, where it regulates the proliferation and migration of 
neural progenitor cells (Huang et al. , 201 0) . 
Hh pathway as a chemoattractant: Hh proteins act as chemoattractant on 
axons (Charron et al., 2003) and guide neural cell migration during embryonic 
development. They also promote migration of endothelial cells (Asai et al., 2006), 
oligodendrocyte precursors (Merchant et al., 201 0), and human monocytes 
(Dunaeva et al., 2010). 
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1.3.6 Relevance to Mesothelial cells 
Recent studies on epicardium have shown that Wntlr3-catenin is not active in lung 
mesothelial cells and it is not required for lung mesothelial migration, leading us 
to examine the potential role of other signaling pathways including Hh pathway. 
Based on the known role of Shh in regulating lung development, EMT, 
proliferation, and chemoattraction, we postulated that Hh signaling controls key 
events that underlay the entry and migration of mesothelial cells into lung 
parenchyma. Chapter 3 will address this question . 
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1.4 WT1- Wilms Tumor 1 
1.4.1 Summary 
Wilms tumor-1 (WT1) is a transcription factor specifically and selectively 
expressed in mesothelial cells lining the lungs and other coelomic cavities . 
Recent studies have demonstrated that cells arising from the mesothelium 
contribute to differentiated mesenchymal components of the lungs, heart, liver, 
and gut during organogenesis, and are involved in injury-associated remodeling 
process (Zhou et al., 2008). However, the role of WT1 in lung development and 
repair after injury remains largely unexplored. This chapter reviews the role of 
WT1 in embryogenesis and explores potential interaction of WT1 with protein 
partners in lung mesothelial cells. 
1.4.2 Introduction 
Wilms tumor is a nephroblastoma, primarily caused due to mutations in the tumor 
suppressor gene, Wilms tumor 1 (WT1 ). This tumor accounts for 95% of all 
pediatric cancers affecting 1:10,000 children each year in North America (Ehrlich 
2009; Mclean and Buckley 201 0). Mutations in WT1 are also seen in 
malignancies such as lung cancer (Oji et al., 2002), breast cancer (Silberstein et 
al., 1997), leukemia (Inoue et al., 1994; Tamaki et al., 1999), desmoplastic small 
round cell tumors (Lae et al., 2002), and retinoblastoma (Wagner et al., 2002). 
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The biology of WT1 is complex, in addition to its function as a tumor 
suppressor gene; WT1 regulates epithel ial-mesenchymal interaction required for 
the development of mesodermally derived organs including the kidneys, gonads, 
cardiac vasculature, and spleen. Furthermore, WT1 controls proliferation of 
kidney and neuronal progenitors during embryonic development (reviewed by 
Kriedberg, 2010) . Despite extensive research, the mechanism by which WT1 
influences organ development and tumorigenesis remains poorly understood. 
1.4.3 WT1 gene and protein products 
The human Wilm's tumor 1 gene (WT1) maps to chromosome 11 p13. It consists 
of 1 0 exons and spans about -50 kb. The WT1 gene encodes four Zinc fingers 
(exons 7, 8, 9, 10) at the C-terminal COOH-domain while the N terminal NH2-
domain contains both transcriptional activation and repression sites (Fig . 5) . Four 
major WT1 protein isoforms are produced after two major alternative splicing 
events that involve exon five and nine. The alternatively spliced exon 5 occurs 
only in placental mammals (Kent et al., 1995) and it results in the presence or 
absence of 17 amino acids positioned between the transcriptional regulatory and 
DNA-binding domains of WT1. Splicing event at the 3' end of exon 9 results in 
the insertion or deletion of three amino acids, lysine, threonine and serine, (KTS) 
between the zinc fingers 3 and 4, that alters the DNA and RNA binding properties 
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of the Wf1 protein . The +KTS isoform preferentially binds to RNA and the -KTS 
isoform binds to DNA (Discenza and Pelletier, 2004; Yang et al, 2007). 
Other isoforms that are derived from Wf1, use either a substitute start site 
or an alternative promoter sequence (Dallosso et al., 2004). In addition , a 
truncated Wf1 isoform that starts at the end of intron 5 has been observed only 
in prostate, breast and leukemia cancer cells (Dechsukhum et al., 2000) . In total, 
the Wf1 isoforms encode for 24-36 different protein products. 
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Figure 5. WT1 gene and protein 
RNA Binding DNA Binding 
···------Frasier Syndrome 
- --------Kidney hypoplasia 
Exons are indicated by blue and introns are in orange. Alternative splice sites 
located within exons 5 and 9 are indicated by triangles. Alternative splice I in 
exon 5, results from inserting or lack of 17 amino acids. Alternative splice II , 
results from inserting or lack of three amino acids. KTS refers to lysine, threonice 
and serine. Shown is ratio of the two isoforms that leads to different outcomes 
(adapted from Discenza and Pelletier 2004). 
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1.4.4 Sites of WT1 expression 
In a mouse embryo, WT1 mRNA is first detected in the intermediate 
mesenchyme adjacent to the coelomic cavity at E9.5. From embryonic day 10.5 
onward , WT1 is expressed in many tissues, including the urogenital system, 
spleen, spinal cord , diaphragm, limb, proliferating coelomic epithelium, 
mesothelial cells lining internal organs such as lungs and heart (Rackley et al. , 
1993; Armstrong et al. , 1993; Moore et al. , 1998; Moore et al. , 1999; Pelletier et 
al. , 1991 ; Dixit et al. , 2013) . In adults, the expression of WT1 is shut down in 
most internal organs with the exception of glomerular podocytes of the kidney, 
sertoli cells of testes , epithelial cells of uterus, ovary, and rare population of bone 
marrow cells (Kriedberg et al., 1993; Langsdorf et al. , 2011 ; Walker et al. , 1994; 
Armstrong et al. , 1993; Pelletier et al. , 1991 ; Siehl et al. , 2003)) . Remarkably, the 
expression of WT1 is reactivated in the adult heart, post-hypoxia and ischemia 
injury (Von Gise et al. , 2011) indicating that WT1 expressed in mesothelial cells 
has a role in wound healing process. 
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1.4.5 WT1 in embryonic development 
The role of WT1 in embryonic development comes from mouse models 
generated to examine the pathology of Wilms tumor. Kriedberg et al (1993) 
generated the first mutant mouse model of WT1. Homozygous mutant mice in 
C57BL/6J background fail to complete gestation and die between embryonic day 
13 and 15 due . to massive edema and pericardia I bleeding. A predominant 
feature of WT1K0 mice is kidney and gonad agenesis. In addition, further defects 
are found in the spleen, diaphragm, heart, lungs, and adrenal gland (Kriedberg et 
al., 1993). 
WT1 in Urogenital system: Mammalian kidney arises during embryogenesis 
from the interaction between differentiated epithelial cells and the undifferentiated 
mesenchymal cells. Loss of WT1 causes mesenchymal cell death and prevents 
nephron formation. Specifically, the -KTS isoform is required for the proliferation 
of primordial mesenchyme whereas the +KTS form is essential for differentiation 
of podocytes and glomerular capillaries (Kriedberg et al., 1993). 
The ratio of the +KTS and -KTS isoforms is conserved rn embryonic 
development. In humans a 50% reduction in the WT1 (+KTS) levels is associated 
with developmental defects such as Frasier syndrome (Fig . 5) (Barbaux et al., 
1997). Further, alterations in the ratio of these isoforms results in congenital 
anomalies, Denys-Drash syndrome and WAGR syndrome (YYilm's tumor, 
Aniridia, Genito-Urinary Anomalies and Mental Retardation) (Scharnhorst et al., 
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2001 ). Glomerular nephropathy is the most common finding in Denys-Drash 
syndrome while gonadal neoplasms and Wilms tumor are a common occurrence 
in patients with Frasier syndrome. Other symptoms include amenorrhea, 
nephrotic syndrome, and male-to-female sex reversal. In rare cases, patients 
with Denys-Drash syndrome have hypoplastic lungs and broncho pulmonary 
dysplasia (Dharnidharka et al., 2001 ). Recent studies examining the long-term 
effects of loss-of-WT1 showed that adult mice with heterozygous mutations in 
WT1 develop nephrotic syndrome, indicating that WT1 can alter kidney function 
in adult life. 
In the uterus, -KTS isoform of WT1 is required for the formation of gonadal 
ridges , whereas +KTS form in XY individuals activates the SRY gene (Sex 
determining region-Y} , a gene that is essential for sex determination. Alterations 
in the ratio of the +KTS and -KTS isoforms of WT1 , alters developmental 
outcome and may lead to male-to-female sex reversal. Moreover, adult mice with 
WT1 mutation have reduced testes and ovaries. 
WT1 in Heart development: Recent lineage labeling studies revealed that WT1 
expressing epicardial cells migrate into the sub-epicardial mesenchyme and give 
rise to cardiomyocytes , vascular smooth muscle cells , fibroblasts, and endothelial 
cells (Zhou et al. , 2008). Mice homozygous for WT1 mutation have a defect in 
coronary vasculature and lack most of the sub-epicardial region. Mortality in the 
WT1 mutant mice is due to pericardia! bleeding and heart failure (Moore et al. , 
1999). Mechanistically, WT1 plays multiple roles in heart development. It is 
required for epithelial-mesenchymal transition of epicardial cells and proliferation 
of cardiac progenitors. Recent studies have shown that loss-of-WT1 function 
decreases Raldh2, canonical and non-canonical Wnt signaling in the epicardium. 
Further, WT1 directly binds and regulates EMT-related genes Snail, Slug, and E-
cadherin. Overall, WT1 is required for EMT and myocardial growth in the 
developing heart (Martinez-Estrada et al., 201 0; Von Gise et al., 2011 ). 
WT1 in other organs: Along with defects in kidney and heart, loss-of-WT1 leads 
to defects in liver, spleen, and diaphragm during embryogenesis (Kriedberg et 
al. , 1993). In the liver, WT1+ cells migrate into the liver and give rise to hepatic 
stellate cells, smooth muscle cells, and fibroblasts (Asahina et al., 2011 ). This 
information has gained enormous interest, due to the role of stellate cells in 
fibrosis and pancreatic cancer (Asahina et al., 2011 ). Loss-of-WT1 in liver, leads 
to hypoplastic liver with defects in lobation (ljpenberg et al., 2007), in spleen, it 
results in small and pale spleen with enhanced apoptosis in primordial spleen 
cells (Herzer et al. , 1999). Homozygous deletion of WT1 causes hypoplastic 
lungs and diaphragmatic hernia (Kriedberg et al., 1993). Diaphragm constitutes 
skeletal muscle and tendon that separates abdominal and thoracic cavities. 
WT1 has shown to be a regulator of homeostasis in adult tissues. Loss-of 
WT1 causes atrophy of exocrine pancreas and spleen, affects bone and fat 
formation and inhibits erythropoiesis (Chau et al., 2011 ). WT1 plays a role in 
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osteoclast and osteoblast formation (bone architecture) and directly affects bone 
homeostasis and repair. WT1 is detected in sub-group of erythropoetic stem 
cells. It directly regulates and activates erythropoietin and affects hematopoiesis 
in adult mice (Chau et al., 2011). 
WT1 also plays important role in neuronal development (Wagner et al. , 
2002). Further, homozygous deletion of Wt1 causes severe abnormalities of 
retina and optic nerve (reviewed by Wagner et al., 2003). 
Overall, WT1 proteins play important biological functions required for 
normal embryonic development and maintenance of adult tissues. 
1.4.6 Potential Protein Partners of WT1 in mesothelial cells 
WT1 is a master regulator that interacts with a number of transcription factors, 
signaling molecules and growth factors. The zinc fingers of WT1 bind to many 
proteins including p53, p73, and Hsp70, to affect cellular events including 
embryonic development, cell survival, differentiation, and proliferation 
(Maheswaran et al., 1993, 1995, 1998; Scharnhorst et al., 2000). Most of the 
research on WT1 comes from studies examining kidney development and Wilms 
tumor; below I discuss potential interactions of WT1 with several protein partners 
in mesothelial cells lining internal organs (Fig. 6). 
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Interaction of WT1 with signaling pathways in mesothelial cells: Recent 
chromatin immunoprecipitation ("ChiP'} with microarray technology ("chip'} 
ChiP-Chip assay performed on primary podocytes in the kidney demonstrated 
that WT1 interactions with several developmental pathways such as Hh pathway, 
Wnt/!3-catenin , Notch signaling, and retinoic acid signaling (Hartwig et al., 2010) 
(see Fig . 6) . In support of this finding , WT1 was found to control canonical , non-
canonical Wnt signaling and Raldh2 expression in epicardial cells, to promote 
EMT and myocardial growth of the heart (Guadix et al. , 2011 ; Von Gise et al. , 
2011 ). Interestingly, RBPjk, the DNA binding partner of all four Notch receptors 
and a core component of canonical Notch signaling , is active in several 
mesothelial cells at E13.5 (Morimoto et al. , 201 0) . In the future, it would be 
interesting to examine whether Notch signaling is required for mesothelial cell 
differentiation into smooth muscle cells and fibroblasts. 
WT1 regulates EMT in mesothelial cells: EMT-related genes such as Snail, 
Twist and E-cadherin are direct targets of WT1 in multiple organs during 
development and disease (Hartwig et al. , 2010). In the heart, epicardial EMT was 
defective with loss-of WT1 function indicating a direct relationship between WT1 
and EMT-related genes in cardiac development (Martinez-Estrada 2010; Von 
Gise 2011 ). In the lung , we recently demonstrated that expression of EMT genes 
Snail2 and Twist1 is significantly downregulated in fetal lung mesothelial cells 
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with loss-of WT1 function (Refer to Chapter 4, Fig. 21 ). However, future studies 
need to clarify if WT1 expressed in lung mesothelial cells directly targets EMT-
related genes or it regulates through an unknown signaling pathway such as 
Wnt1~-catenin or Notch signaling. 
WT1 in ECM modification: In sertoli cells of testes , WT1 directly binds and 
regulates Sulfatase 1 and Sulfatase 2, heparan sulfate modifying enzymes to 
regulate GDNF (Glial cell line-derived neurotrophic factor) signaling for sertoli 
stem cell niche maintenance. Heparan sulfate proteoglycan , an extracellular 
matrix glycoprotein is essential for FGF ligand-receptor binding and activation 
(Langsdorf et al. , 2011 ). Sulfatase 2 modulates Hh pathway and FGF signaling 
and is expressed only in mesothelial cells in the lung (Ornitz, 2000; Lin and 
Perrimon , 2003) . Interestingly, shh transports across field of cells only in the 
presence of heparan sulfate. Future studies would need to examine the 
interaction of WT1 with ECM proteins in lung formation and disease processes. 
WT1 regulates growth factors: Studies in the urogenital system and heart have 
indicated that WT1 regulates a number of growth factors such as epidermal 
growth factor and fibroblast growth factors , TGF,B/BMP, PDGF, and VEGF 
(Hartwig et al. , 2010). Growth factors such as VEGF, PDGFa, PDGF~ , FGF9, 
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and FGF10 are required for pulmonary vascular development, smooth muscle 
and myofibroblast formation in the lung parenchyma (Morrisey and Hogan 201 0) . 
WT1 regulates SRF: Previously, we have demonstrated that WT1 + mesothelial 
cells give rise to smooth muscle and fibroblasts in the lung. However, the 
molecular pathways that allow mesothelial progenitors to differentiate into 
mesenchymal cells need to be further studied . Smooth muscle formation, 
differentiation and proliferation , is tightly controlled by serum response factor 
(SRF) (Camoretti-Mercado et al. , 2003). In the heart, proepicardial cells require 
active serum response factor to differentiate to coronary smooth muscle cells 
(Landerholm et al. , 1999). 
1.4. 7 Perspective 
The function of WT1 in lung development is not known , but it can be speculated 
that WT1 interacts with multiple signaling molecules required for lung 
mesenchyme formation. In the future, Chromatin immunoprecipitation and loss-of 
function studies could be conducted to examine the interaction of individual 
pathways with WT1 , and ultimately decipher the role of WT1 in lung development 
and disease. 
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Figure 6. Potential interaction of WT1 with protein partners to regulate lung 
development 
Vegfa 
'\ 
-..-:---~Hh 
WT1, a transcription factor expressed in mesothelial cells (shown in red) interacts 
with a number of signaling pathways by directly regulating their transcriptional 
activity to influence the expression of genes required for mesenchyme formation 
in the lung parenchyma. Note: WT1, Raldh2, Rbpjk, and Sulf2 are all expressed 
in mesothelial cells, but have been depicted outside. Hh- Hedgehog, RA-
Retinoic acid, Raldh2- Retinaldehyde dehydrogenase-2 , Sulf2- Sulfatase-2, 
Vegfa - Vascular endothelial growth factor a, Wnt- Wingless type, WT1- Wilms 
tumor 1. 
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Chapter 2 OVERVIEW 
The goal of this project was to elucidate the fate and regulation of mesenchymal 
progenitors that are derived from the mesothelium and to identify the key signals 
regulating mesothelial cell entry in lung development. 
Three hypotheses were proposed for the study. 
1) Mesothelial cells give rise to specific types of differentiated mesenchymal cells 
in the developing mouse lung (addressed in chapter 4.1) 
2) Hh signaling facilitates mesothelial cell entry into the underlying lung 
parenchyma (addressed in chapter 4.1) 
3) WT1 controls downstream constituents of Hh pathway in mesothelial cells 
(addressed in chapter 4.1) 
To rigorously address the first two hypotheses (chapter 4), we employed 
WT1creERT2!+ mice for high fidelity lineage tracing after confirming that Cre-
recombinase was mesothelial-specific and faithfully recapitulated endogenous 
Wilm 's tumor 1 (WT1) gene expression. We visualized WT1+ mesothelial cell 
entry into the lung by live imaging and identified their progenies in 
subpopulations of bronchial smooth muscle cells, vascular smooth muscle cells, 
and desmin+ fibroblasts by lineage tagging (see Fig. 7). Derivation of these 
52 
lineages was only observed with Cre-recombinase activation during early lung 
development. Using loss-of-function assays in organ cultures , and targeted 
mesothelial-restricted loss-of hedgehog function mice, we demonstrated that 
mesothelial cell movement into the lung requires the direct action of hedgehog 
signaling. In contrast, hedgehog signaling was not required for fetal mesothelial 
heart entry. Our findings further support a paradigm wherein the mesothelium is 
a key source of progenitors for mesenchymal lineages during organogenesis and 
indicate that signals controlling mesothelial cell entry are organ-specific. 
To examine the functional relationship between Wilm's tumor 1 (WT1) , Hh 
pathway and EMT in mesothelial cells, our third hypothesis (chapter 4.2) , we 
conducted chromatin immunoprecipitation and dual luciferase reporter assay to 
show that WT1 directly binds and regulates Hh pathway constituents in lung 
mesothelial cells. Further, to assess the function of WT1 in the lung, we 
generated WT1 loss-of function mice in 86 and mixed genetic background . 
WT1 K0 lungs in a mixed genetic background , were smaller than controls and had 
reduced expression of smooth muscle actin in the distal lung. Further, expression 
of Hh pathway and EMT-related genes were significantly downregulated m 
isolated fetal mesothelial cells. Collectively, we demonstrate that WT1 is 
essential for normal lung development and is upstream of Hh pathway in lung 
mesothelial cells. 
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Figure 7. Overview of the project 
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Cartoon summarizing the project. WT1 positive mesothelial cells enter the lung 
parenchyma with the direct action of Hh signaling and WT1 itself. The expression 
of WT1 is shutdown after lung parenchymal entry as they differentiate into 
mesenchymal cells . WT1- Wilms tumor1 , Hh-Hedgehog, BSM- Bronchial smooth 
muscle, VSM- Vascular smooth muscle 
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Chapter 3 MATERIALS AND METHODS 
3.1 Mice 
All original mouse lines were purchased from Jackson laboratories followed by 
mating to generate experimental mouse lines in our study (Table 1). The WT1 
heterozygous mouse strains were backcrossed 5 generations onto C3H/HeJ 
background and genotyped according to the protocol provided. For timed 
pregnancy, identification of the vaginal plug was considered as embryonic day 
0.5 (E0.5) . To activate CreERT2, 1 mg TAM (5 mg/ml, Sigma) was injected intra-
peritoneally per dose. C-sections were performed on animals that developed 
dystocia. The pups were fostered with CD-1 timed pregnant mothers. All mouse 
procedures were performed in accordance with approved protocols by IACUC at 
Boston University School of Medicine. 
3.2 Immunohistochemistry and Detection of J3-galactosidase activity 
Sections of formalin-fixed Rhesus macaque lung tissues (5 pm) were kindly 
provided by Dr. Alice Tarantal, National Heart, Lung, and Blood Institute (NHLBI) 
Center for Fetal Monkey Gene Transfer for Heart, Lung, and Blood Diseases. 
Dissected mouse lungs were fixed in 4% paraformaldehyde (PFA)/PBS prior to 
embedding and sectioning. 8 pm tissue sections were blocked in 2.5% goat 
serum or MOM block (Vector Laboratories). High pH antigen retrieval (Vector 
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Laboratories) was used when staining for mesothelin and WT1. Primary 
antibodies used include: FITC-conjugated anti-a-smooth muscle actin (a-SMA) 
(1: 100, Sigma), anti-WT1 (1 :200, Dako), anti-desmin (1: 100, Sigma), anti-Snail2 
(1:100, Cell Signaling), anti-Ki67 (1 :100, BD Biosciences), anti-mesothelin 
(1: 1000, Abbiotec) . Antigen-antibody complex was visual ized by fluorescence or 
DAB. 
Staining for LacZ expression was performed using established protocol 
(Hogan et al., 1994). After staining, sections were washed in PBS, post-fixed with 
4% PFA for 4 hr and processed for paraffin embedding. 5 j.Jm paraffin sections 
were deparaffinized, dehydrated, and counterstained with nuclear fast red. 
3.3 In situ Hybridization 
WT1 mRNA expression on 8 j.Jm lung frozen sections was assessed by in situ 
hybridization as previously described (Ai et al., 2007). The WT1 antisense probe 
was generated from a 1.4 kb WT1 eDNA (Gao et al., 2005). 
3.4 RT-PCR 
Total RNA was isolated using an RNeasy mini kit (Qiagen). eDNA was 
transcribed using the GoScript reverse transcription system (Promega). All 
taqman probes were obtained from Applied Biosystems and all SYBR primers 
were ordered from IDT. Quantitative real time PCR (qRT-PCR) was performed 
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using a Step One plus instrument (Appl ied Biosystems). Assays were performed 
in triplicate and either normalized to 18s RNA (Taqman) or GapdH (SYBR) . 
Relative gene expression was calculated by the 2-MCT method (according to 
manufacturer's protocol). See Table 2 for Taqman and SYBR primer details. 
3.5 Lung explant cultures and time lapse Live Imaging 
WT1 creERT2f+,Rosa(tmRed) pregnant mice were injected with TAM at E10.5 and 
E11.5 and embryos were harvested at E12.5. Lungs were cultured on transwell 
inserts (Corning) in the presence of cyclopamine (0.5 !JM, Calbiochem) or DMSO 
vehicle (Radzikinas et al. , 2011). After 24 hr, lungs were processed for analysis. 
For live imaging, tmRed+ lungs were isolated from mice that were administered 
with one dose of TAM at E10.5 . The lungs were cultured for 24 hours on 
transwell insert and transferred to a glass bottom culture dish, placed in a 3i C 
humidified chamber and imaged for 2.5 hours using a Zeiss LSM 710 Live-Duo 
Scan 2 photon confocal microscope, with a 20x objective. For each lung, three 
different locations were imaged. Transmitted light was used to visualize the edge 
of the lung. The data were analyzed using Zen 2011 software from Carl Zeiss. 
Movies were generated for each focal plane and exported to a Quicktime format 
at 2 frames per second . 
57 
3.6 Cell quantification 
To quantify tmRed+ cells in the parenchyma of lung explants, sections from three 
vehicle-treated controls and from three cyclopamine-treated lungs were 
analyzed . For in vivo mesothelial loss-of-Hh signaling studies, 10 lung sections 
from each mouse were examined . TmRed+ cells in the lung parenchyma were 
calculated per defined lung areas quantified using NIH Image J (Schneider et al., 
2012) . 
3. 7 Relative quantification of tmRed+ bronchial smooth muscle 
To measure the relative percent of the smooth muscle area around bronchi , that 
is tmRed+, lung sections were immunostained with a-smooth muscle actin 
(alpha-SMA). After imaging medium-sized airways, NIH Image J (Schneider et 
al., 2012) was used to quantify the total alpha-SMA immune-reactive area and 
the area that was concomitantly tmRed+. 10 airways from 5 mice were 
examined . 
3.8 Cell sorting 
WT1GFP+ cells were collected from lung cell suspensions of E13.5 WT1creGFPI+ 
mouse embryos, using a MoFio cell sorter (Beckman Coulter, Fullerton, CA). 
3000-4000 GFP+ cells per whole fetal lung per each animal were collected for 
experimental analysis. 
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3.9 293T cell culture 
293T human embryonic kidney cells were grown in Dulbecco's modified Eagle's 
medium with 10% fetal bovine serum and 1% antibiotics (Invitrogen) . 
3.10 Chromatin lmmunoprecipitation 
Isolated fetal lung mesothelial cells collected from 16 embryos were treated for 
1 h in 1% PFNPBS at room temperature to cross-link chromatin and associated 
proteins. Sonication was used to break the DNA into 400-500 bp fragments, and 
the supernatant was collected by centrifugation. One-fifth of the supernatant 
( 1 00 j.JL) was then incubated with 5 j.Jg of the WT1 antibody ( 1:1 00, Santa Cruz 
Biotechnologies) or 5 j.Jg of rabbit lgG isotype control in a final volume of 300 j.JL 
overnight at 4° C. Complexes were pulled down using protein NG beads 
(Fisher). The DNA fragments were released by protease K treatment of the 
pulldown followed by incubation at 65° C overnight to reverse the cross-link. After 
purification , the DNA was used in PCRs using primers from Table S2 of Hartwig 
et al. , (2010). 
3.11 Constructs, mutagenesis and dual luciferase assay 
Wild-type Smo promoter sequences were cloned into p TEasyvector (Promega) 
by PCR. The predicted WT1-binding sites were mutated by converting G/C into 
NT by PCR. After sequencing, both wild-type and mutated Smo promoter 
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sequences were inserted into pGL3-Basic vector (Promega) to generate pSmo-
firefly luciferase constructs . To measure promoter activities, 293T cells in 24-well 
culture plates were transfected with two luciferase reporter constructs and an 
expression vector as follows: 1 00 ng of pSmo-firefly /uciferase , 1 0 ng of p TK-
renilla /uciferase to control for transfection efficiency and 200 ng of the 
expression vector for either WT1 or empty vector control. Cell transfection was 
performed using the Fugene 6 reagent (Roche). After 48 h, cells were lyzed and 
subjected to dual luciferase assay using Glomax Multi Detection System 
(Promega). The transcriptional activities of cloned promoters were quantified by 
dividing firefly /uciferase activity by renilla luciferase activity. Experiments were 
repeated three times with individual samples in triplicates. 
3.12 Data analysis 
Data are presented as mean ± standard error (SEM) . Statistical analyses were 
performed using a Student's t test. p <0.05 were deemed significant. 
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Table 3. Mouse lines 
Mouse Lines Construct Purpose/ Readout 
WT1creERT2 Loss-of-function WT1 allele Lineage trace WT1 
resulting from a knock-in TAM expressing mesothelial 
WT1GFPCre The exon 1 of WT1 gene was GFP+ cells contain 
replaced with eGFP-ere fusion active WT1 promoter. 
construct Mice can also be used 
for lineage tagging 
Rosa- Tomato Red protein gene driven Reporter mice used for 
CA G'5 tdTomato by GAG promoter in the Rosa lineage tagging 
locus. Tomato Red (TmRed) is 
expressed upon ere-excision of 
the floxed stop. 
Rosa-LacZ The gene of {3-ga/actosidase or Reporter mice used for 
the LacZgene that is ubiquitously lineage tagging 
driven by the Rosa promoter is 
expressed upon ere-excision of 
the floxed stop. 
Ptch1LacZ LacZ Knock-in reporter in the A reporter line with 
Patched11ocus . active Hh signaling 
G /i 1 CreERT2 ereERT2 fusion protein gene is To lineage label cells 
knocked into the Gli1 locus with active Hh signaling 
G/i1Lacz LacZ Knock-in reporter in the Gli1 A reporter line with 
locus. active Hh signal ing 
ShhCre ererecombinaseknocked into To lineage trace Shh 
theShh locus ligand expressing cells 
Smotlt Homozygous floxedSmoothened For loss-of -H hfunction 
alleles. Hh signaling is inactivated studies in mesothelial 
upon ere-removal of the lineages after crossing 
floxedSmo gene. with WT1creERT2!+ mice 
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Table 4. Primers for Real time PCR 
Gene Prime~ID-TaqManprime~ Applied Biosystems 
Eukaryotic 18S rRNA 
Endogenous Control 4319413E 
(VIC/MGB Probe) 
WT1 Mm01337048 m1 
Gli1 Mm00494654 m1 
Patched1 Mm00436026 m 1 
Smoothelin Mm00449973 m 1 
Mesothelin Mm00625546 m 1 
Myocd Mm00455051 m1 
Smoothelin Mm00449973 m 1 
Nkx2.1 Mm0044 7558 m 1 
SMA (ACTA2) F AGCCAGTCGCTGTCAGGAACCCT 
SMA (ACTA2) R CACCAGCGAAGCCGGCCTTAC 
GapdH AACCAGAAGACTGTGGATGG CACATTGGGGGTAGGAACAC 
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Chapter 4. RESULTS AND DISCUSSION 
4.1 Derivation of lung mesenchymal lineages from the fetal mesothelium 
requires hedgehog signaling for mesothelial cell entry 
4.1.1 RESULTS 
4.1.1.1 Identification of WT1 as a selective fetal lung mesothelial cell marker 
In order to assess whether WT1 can serve as a specific marker of the fetal lung 
mesothelium, we analyzed the expression of WT1 mRNA and protein by in situ 
hybridization and immunohistochemistry, respectively. We found that WT1 is 
localized exclusively and uniformly in visceral mesothelial cells covering the 
surface of the lung and parietal mesothelial cells lining the thoracic cavity 
between E10.5 and E14.5 (Fig. 8A-C, G-H). As development proceeds, 
expression of WT1 was shut down in an increasing number of visceral 
mesothelial cells and , ultimately, was not detected in any adult mesothelial cell 
(Fig. 80-F, 1) . The dynamics of WT1 mRNA expression was corroborated by 
qRT-PCR of whole mouse lung RNA (including visceral mesothelium) (Fig. 9A) . 
At all-time points , we did not find any cells in the lung parenchyma that express 
WT1 mRNA or protein (Fig. 8A-I). A similar temporal expression pattern for WT1 
was found in Rhesus macaque lungs (Fig. 98) , indicating conserved WT1 
expression across mammalian species. In contrast, mesothelin, another putative 
mesothelial marker, was not expressed in the early lung mesothelium, though it 
was detected in the heart mesothelium (Fig. 9C) . 
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Figure 8. Characterization of WT1 expression in lung mesothelial cells 
(A-F) Restricted and temporal WT1 mRNA expression in the lung mesothelium 
from E1 0.5 to adult as analyzed by in situ hybridization. Arrows point to the 
visceral mesothelium and arrowheads point to the parietal mesothelium. (G-1) 
WT1 immunohistochemistry in the embryonic lung. Arrows point to WT1+ 
mesothelial cells. Scale bars, 50 pm in A-1 and 100 pm in E, F. 
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Figure 9. Characterization of WT1 and Mesothelin expression in mesothelial 
cells 
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(A) Temporal expression of WT1 mRNA in developing mouse lungs. Total RNA 
was extracted from whole lungs (including overlying mesothelium) of mouse 
embryos and postnatal day 7 (P7) pups before subjecting to qRT-PCR. Results 
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were normalized to 18s RNA. Data represent mean .±. SEM from 3 mice for each 
age group. (B) Characterization of WT1 expression in Rhesus macaque lungs. 
WT1 immuno-labeling in mid-gestational (64 days) and neonatal (P30) Rhesus 
macaque lungs. WT1 protein is detected in fetal lung mesothelium (black arrow) 
but not in P30 lung. (C) Differential expression of mesothelin in the visceral 
mesothelium of the lung and the epicardium of the heart at E11.5, E12.5 and 
E14.5. Arrows point to mesothelin+ epicardial cells. Scale bars, 50 J.lm and 100 
J.lm . 
66 
4.1.1.2 Validation of the WT1creERT2!+ mouse for genetic labeling of fetal 
mesothelial cells and their lineages 
The restricted expression of WT1 to the fetal lung mesothelium indicated that the 
TAM-inducible knock-in WT1 creERT2!+ mouse may be an effective tool to study 
fetal mesothelial cell migration and fate during lung development. To establish 
this, we crossed the WT1creERT2!+ mouse with a Rosa(tmRed) reporter and 
administered TAM at various time points. Lungs were harvested for evaluation of 
ere-dependent expression of a red fluorescent marker (tmRed). No tmRed+ cells 
were detected in WT1creERT2!+,Rosa(tmRed) mice that did not receive TAM (data 
not shown). In addition , tmRed+ cells were not detected in E18.5 mouse lungs 
from animals that received a single dose of TAM (E5 or E8) prior to 
establishment of the lung primordium. Notably, a single dose of TAM at E10.5 
labeled only visceral mesothelial cells in lungs isolated 24 hours later (Fig. 1 OA) , 
indicating that Cre expression in the WT1creERT2!+ fetal mouse lung faithfully 
recapitulates WT1 expression. After 2 doses of TAM at E10.5 and E11 .5, the 
entire visceral mesothelium was tmRed+ in lungs harvested at E12.5, E14.5, 
E18.5, and P21 (Fig. 1 OB,E), showing highly efficient ere-mediated 
recombination. In mice that received TAM injections at later gestational time 
points, however, there was diminished mesothelial labeling (Fig. 1 OF,G), 
consistent with the declining expression of WT1 as development advances (Fig. 
8) . Collectively, these findings demonstrate that WT1 is a marker of early 
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embryonic lung mesothelium and that the WT1creERT2/+ mouse is an efficient and 
faithful tool for characterization of mesothelial cell migration and lineage 
relationships during lung development. 
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Figure 10. Mesothelial cell entry into the lung parenchyma 
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(A-E) Examination of tmRed+ cells in the lungs of WT1ca£RT2!+;Rosa(tmRed) mice 
at various time points after 1 or 2 doses of TAM at E1 0.5 and E11.5. Arrowheads 
point to tmRed+ mesothelial cells and white arrows point to tmRed+ cells in the 
lung parenchyma, magnified in inset. (F-G) Analysis of tmRed+ cells in the lungs 
of WT1creERT2I+,Rosa(tmRed) mice at P21 after 2 doses of TAM at E14.5 and 
E15.5 (in F) or at E17.5 and E18.5 (in G). Arrowheads point to scattered tmRed+ 
cells in the lung mesothelium. White arrows point to tmRed+ cells in the lung 
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parenchyma. (H) TmRed+ mesothelial cells (arrowheads) and tmRed+ cells that 
straddle the surface and the parenchyma of the lung (white arrow) at E14.5 in 
WT1creERT2f+;Rosa(tmRed) mice that received 2 doses of TAM at E10.5 and 
E11.5. Insert shows the enlarged image of the straddling tmRed+ cell. (1-L) Time-
lapse images of a tmRed+ lung explant by live confocal imaging. E12.5 lungs 
were isolated from TAM-treated WT1creERT2f+,Rosa(tmRed) mice and were 
cultured on transwell inserts for 24 hours before imaging. Sequential movie 
frames from a single Z-focal plane shows the movement of a tmRed+ cell (arrow 
and magnified in inset) from the mesothelium into the lung parenchyma over 150 
minutes. Appearance of three additional tmRed+ cells into this focal plane over 
150 minutes is indicated by white circle. Scale bars, 50 J.lm . Note, the gray 
contours of the underlying lung are due to transmitted light. 
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4.1.1.3 Migration of fetal mesothelial cells into the lung 
TmRed+ mesothelial cells appear thin and flat on the surface of the lung in TAM 
treated WT1 creERT2I+,Rosa(tmRed) mice (injection at E1 0.5 and E11 .5) (Fig . 
1 OA,G). However, tmRed+ labeled ce lls with a rounded morphology were found 
straddling the surface and parenchyma of the lung at E14.5 (Fig. 1 OH) , 
suggesting entry into the underlying lung. Consistent with mesothelial cell 
migration from the surface, tmRed+ cells were also found deeper within the 
parenchyma at E12.5, E14.5, E18.5, and P21 (Fig. 108-E). Overall, the tmRed+ 
mesothelium-derived cells accounted for approximately 5% of total lung 
parenchymal cells at E14.5. With later gestational TAM injections at E14.5 and 
E15.5, a reduced number of tmRed+ parenchymal cells were observed (compare 
Fig. 1 OE to 1 OF). In addition, no tmRed+ parenchymal cells were found in 
postnatal lungs after TAM injections at E17.5 and E18.5, although a few 
scattered visceral mesothelial cells were labeled (Fig. 1 OG). These observations 
suggest that WT1+ mesothelial cells enter the fetal lung parenchyma up until 
approximately E 17. 
In order to prove that WT1+ mesothelial cells actively migrate into the lung 
parenchyma, we conducted time-lapse live imaging of lung explants. For this, 
tmRed+ lungs were harvested from E12.5 WT1creERT2I+,Rosa(tmRed) mice after 
one dose of TAM given at E1 0.5. The lungs were then cultured for 24 hours in an 
air-liquid interface prior to live imaging using a two photon confocal microscope. 
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Images of cells at discrete focal planes were collected every 10 min over 2.5 
hours. During imaging, we observed thin flat shaped tmRed+ mesothelial cells 
moving from the surface into parenchymal lung regions whereupon they attained 
a rounded morphology (Fig. 1 01-L) . In addition , we also observed tmRed+ cells 
that were initially out of the focal plane but later appeared during the course of 
live imaging, consistent with cell movement along a vertical axis. 
4.1.1.4 Lineage analysis of fetal mesothelial cells in the lung 
We performed detailed lineage analysis of the early fetal lung mesothelium using 
WT1creERT2!+;Rosa(tmRed) mice. TAM was administered at E10.5 and E11.5 and 
lungs were harvested at E18.5 and at several post-natal time points (P?, P14, 
and P21). At all times examined, tmRed+ cells that co-express a-SMA were found 
circumferentially positioned around airways, indicative of a BSM fate (Fig. 11A-
D). These cells comprised a distinct subset of the total BSM compartment. 
Among 5 different lungs analyzed, 14% to 60% of airways contained at least 1 or 
multiple tmRed+ BSM cells (Fig . 13A). The percent of smooth muscle surface 
area derived from the mesothelium ranged from 22% to 81% (Fig. 138). 
Administration of TAM at the time of lung bud formation (E9.5 and E10.5) 
revealed a similar pattern of tmRed+ cell infiltration and tmRed+ BSM 
mesothelial-derived cells at E18.5 (Fig. 12). In the post-natal lung only, we 
observed tmRed+ cells that co-express a-SMA in the walls of pulmonary arteries 
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and veins, indicative of a vascular smooth muscle fate (Fig . 11 E-G). We also 
found tmRed+ peri-bronchiolar cells with a fibroblastic morphology that were a-
SMA and desmin+ (Fig . 11 H) , indicating a fibroblast cell fate. 
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Figure 11. Lineage tracing of fetal lung mesothelium using 
WT1 creERT2!+;Rosa(tmRed) mice 
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TAM was given at E10.5 and E11 .5 and the lungs were examined at E18.5, P7, 
P14, and P21 for tmRed+ cells that co-express SMA or desmin. (A-D) 
Colocalization of tmRed and SMA in a subset of bronchial smooth muscle cells 
(arrowheads) from E18.5 to P21. Vascular smooth muscle cells (marked by * in 
A) were not labeled with tmRed at E18.5. (E-G) Colocalization of tmRed and 
SMA in postnatal vascular (E, F) and venous (G) smooth muscle cells 
(arrowheads). (H) Colocalization of tmRed and desmin in fibroblast cells around 
the airway at P21 (arrowheads). Nuclei were counterstained with DAPI (Blue) . 
74 
Figure 12. Lineage tracing of fetal mesothelium at the time of lung bud 
formation 
TAM was given at E9.5 and E10.5 to WT1creERT2!+;Rosa(tmRed) mice and the 
lungs were examined at E18.5. (A-C) Colocalization of tmRed and SMA in a 
subset of BSM cells (arrowheads) . Nuclei were counterstained with DAPI (Blue). 
Scale bars; 50 J.lm . 
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Figure 13. Relative contribution of fetal mesothelium-derived airway 
smooth muscle 
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E18.5 tmRed+ lungs were isolated from WT1creERT2!+;Rosa-CAG'5 tdTomato mice 
after TAM treatment at E10.5 and E11.5. Lungs were sectioned and immuno-
labeled with an anti-SMA antibody conjugated with FITC. (A) Percent airways 
that contained at least one tmRed+ SSM. Five embryonic lungs were analyzed 
with 10 sections for each embryo. Data represent the average ± SEM for each 
embryo. E-Embryo. (B) Relative percent of the smooth muscle area around 
bronchi that is mesothelial-derived. Image J was used to quantify the total alpha-
SMA immune-reactive area and the area that was concomitantly tmRed+. 10 
airways from 5 mice were examined . 
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4.1.1 .5 Active Hh signaling in WT1 + fetal mesothelial cells 
We next sought to identify signals that might control the entry of fetal visceral 
mesothelial cells into the lung parenchyma. We focused on the Hh pathway due 
to its specialized role in cell migration and EMT (Polizio et al., 2011; Yoo et al. , 
2011) and because of previous work in the fetal kidney where it was shown that 
WT1 regulates expression of Hh pathway constituents (Kreidberg et al. , 1993; 
Hartwig et al. , 201 0) . Using three independent reporter mouse lines (Table 3), we 
examined whether the Hh pathway was active in the embryonic lung 
mesothelium between E10.5 and E16.5, a time-frame that coincides with WT1 
expression and mesothelial cell entry. The first reporter was a knock-in Ptc1LacZ/+ 
mouse where LacZ expression parallels Ptc1 expression , a direct downstream 
target of Hh signaling (Bellusci et al., 1997). At E14.5, we found abundant f3-gal+ 
cells in the lung visceral mesothelium, indicative of active Hh signaling (Fig. 14A). 
To confirm this observation, we sacrificed the Gli1 1acZ/+ transgenic reporter 
mouse (Bai et al. , 2002) at E14.5 and similarly found lacZ+ visceral mesothelial 
cells (Fig. 148). For further validation, we employed the Gli1creERT2!+,R26RiacZ 
knock-in reporter mouse, which contains a TAM-inducible Cre under the control 
of the Hh signaling target, Gli1 (Ahn and Joyner, 2005). This mouse was given a 
single dose of TAM between E10.5 and E14.5 and the lungs were analyzed at 
E16.5. f3-gal+ cells were found in the visceral mesothelium (Fig . 14C, Fig. 15A) 
but not in the parietal mesothelium (Fig . 15A). Consistent with published findings, 
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1n all three reporter m1ce, active Hh signaling was also observed m other 
mesenchymal compartments including the sub-mesothelium and BSM. Notably, 
we did not detect any Hh responsive cells in the heart mesothelium of TAM-
treated Gli1creERT2I+;R26R/acZ embryos (Fig. 140). This latter finding is 
consistent with an earlier role of Hh in heart field specification (Thomas et al. , 
2008). Collectively, these results demonstrate that the Hh pathway is active in 
the lung visceral mesothelium during a period that overlaps with WT1 expression 
and cell entry into the fetal lung parenchyma. 
To identify the source and identity of the Hh ligand for mesothelial 
signaling , we assessed mRNA expression for all three Hh ligands in E14.5 lungs 
by qRT-PCR. We found that Shh was the most abundantly expressed whereas 
/hh and Dhh were expressed at nearly undetectable levels (Fig. 158). We then 
performed in situ hybridization and lineage tracing using Shhcrei+;R26R/acZ mice 
to identify Shh-producing cells . Both assays showed that Shh is only expressed 
in the lung epithelium (Fig . 15C, 140), consistent with a paracrine mode of Hh 
signaling to the fetal visceral mesothelium. Notably, we did not detect Shh 
expression in the visceral or parietal pleura. 
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Figure 14. Active Hh signaling in fetal lung mesothelial cells 
(A) E14.5 Ptc11acZI+ mouse lungs contained 0 -galactosidase+ visceral 
mesothelial cells marked by arrowheads (magnified in insets) and 0 -
galactosidase+ sub-mesothelial and BSM cells. Nuclei were stained with nuclear 
fast red . (B) E14.5 Gli11acZI+reporter mice contained 0 -galactosidase+ visceral 
mesothelial cells (arrow heads) and 0 -galactosidase+ lung mesenchymal cells 
(arrow). (C) Analysis of Hh signaling in Gli1creERT2I+,R26RiacZ reporter mice. 
TAM was injected at E12.5 and lungs were examined at E16.5. 0 -galactosidase+ 
cells were found in the lung mesothelium (arrowheads) , BSM cells (arrow), and 
lung mesenchyme but not in the heart. * marks the area enlarged in insets. Scale 
bars, 50 IJm. 
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Figure 15. Characterization of Hh signaling and Hh ligand expression in 
embryonic lung 
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(A) Differential Hh signaling activities in visceral and parietal mesothelium. Lungs 
were dissected from E16.5 Gli1creERT2!+,R26R/acZ mice after TAM injection at 
E12.5. Cells in visceral mesothelium expressed 13-galactosidase (marked by 
asterisk *), indicative of active Hh signaling. In contrast, cells in parietal 
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mesothelium (arrows) did not exhibit active Hh signaling, as indicated by a lack of 
f3-galactosidase activity. Nuclei were stained with nuclear fast red. (B) Relative 
mRNA levels of Shh, /hh and Dhh in E14.5 lungs as determined by qRT-PCR. 
Results were normalized to 18s RNA. Data represent mean .±. SEM from 3 
different mice. (C,D) Expression of Shh in developing lung epithelium assayed by 
in situ hybridization at E13.5 (C) and by lineage labeling using Shhcrei+;R26RiacZ 
mice at E14.5 (D). No Shh expression was observed in visceral mesothelium 
(arrowheads). Scale bars, 50 Jlm. 
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4.1.1.6 Hh Signaling is required for WT1 + fetal mesothelial cell entry into the 
lung 
To further examine the role of Hh signaling in WT1+ mesothelial cell entry, we 
isolated lungs from E12.5 WT1creERT2!+,Rosa(tmRed) embryos after two doses of 
TAM. These lungs were cultured in an air-liquid interface for 48 hours in the 
presence or absence of the Hh pathway inhibitor cyclopamine (Radzikinas et al., 
2011 ). Inhibition of Hh signaling was confirmed by qRT-PCR analysis of 
downstream Hh targets (Fig. 16). In this experiment, we assessed the number of 
tmRed+ cells within the lung parenchyma of 3 DMSO vehicle-treated control 
lungs and 3 cyclopamine-treated lungs. For each lung, tmRed+ parenchymal cells 
in 8 serial sagittal sections were quantified. Compared to control lungs (7.58 +/-
1.18 tmRed+ cells), cyclopamine-treated lungs (2.16 +/- 0.71 , p<0.0003) had an 
approximately 3.5 fold reduction in the number of tmRed+ cells within the lung 
parenchyma (Fig. 17A,B), suggesting that active Hh signaling is required for 
mesothelial cell entry into the lung parenchyma. Consistent with this, live imaging 
of cyclopamine-treated lungs revealed no migration of cells into the lung 
parenchyma (Fig . 17C-F). 
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Figure 16. Examination of Hh activity in lung cultures 
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E11.5 lungs were cultured in the presence of DMSO (vehicle) or 0.5 JJM 
cyclopamine (Hh pathway inhibitor) for 48 hr before gene expression analysis of 
Hh pathway constituents Gli1 and Ptc1 . Results were normalized to 18s RNA. 
Data represent mean± SEM from 3 mice. *p<0.05. 
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Figure 17. Cyclopamine blocks mesothelial cell entry into the lung 
parenchyma in lung explants 
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(A) Effect of Hh pathway inhibition on mesothelial cell entry into cultured fetal 
lungs. E12.5 lungs were isolated from TAM-treated WT1creERT2I+,Rosa(tmRed) 
mice and cultured for 48 hours with DMSO-vehicle (Ctrl) or cyclopamine (Cyclo, 
0.5 pM). * marks mesothelium-derived tmRed+ cells in the lung parenchyma of a 
control lung. (B) Quantification of tmRed+ cells in the lung parenchyma of 
cyclopamine-treated lungs compared to controls . Data represent mean ± SEM 
quantified from 3 control and 3 cyclopamine-treated lungs (8 sections each). 
*p<0.05. (C-F) Time-lapse images of a cyclopamine-treated lung explant by live 
confocal imaging. Shown here are frames of a movie taken from a single Z-focal 
plane over 150 minutes. Scale bars, 50 pm. Note, the gray contours of the 
underlying lung are due to transmitted light. 
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To demonstrate that Shh acts directly on fetal mesothelial cells to induce entry, 
we performed multiple rounds of mating to generate three 
WT1creERT2f+;Smo'~Rosa(tmRed) mice (Table 5) with a rare recombination event 
that resulted in the localization of the floxed Smo gene and the Rosa locus on the 
same chromosome 5. In these mice, TAM administration led to mesothelial 
deficient Hh signaling and concurrent activation of the lineage tag tmRed . 
Confirming disruption of Hh signaling , the Hh target genes G/i1 and Ptc1 were 
significantly down-regulated in loss-of-Hh mutant lungs compared to 
WT1 creERT2f+;Smo'1+,Rosa(tmRed) littermate controls (Fig. 18A,B). Examination of 
lung sections from mutant mice revealed that the mesothelium was similarly 
labeled uniformly, as controls (Fig. 180). There was, however, an approximately 
3.5-fold reduction in the number of tmRed+ cells in the lung parenchyma (0.7 +/-
0.4/unit area, p<0.04) of mutant lungs compared to littermate controls (3 .91 +/-
1.0/unit area) (Fig. 18C,O). This was associated with a significant reduction in the 
expression of multiple smooth muscle associated genes in the mutant mouse 
lung (Fig. 19A). In contrast, mRNA expression of Nkx2.1, a key epithelium-
specific transcription factor, was not affected in loss-of-Hh mutant lungs (Fig . 
19A). Grossly, mutant lungs were smaller and had a more rounded morphology 
at E18.5 (Fig. 198). Importantly, we did not detect any difference in migration of 
tmRed+ cells into mutant versus control fetal hearts (Fig. 180). 
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Table 5. Mating scheme to generate mesothelial loss-of-Hh signaling 
embryos 
Mating pair Progeny 
F1 
WT1creERT21+ (male) WT1CreERT21+;Smofl+ (7/7, 100%) 
Smor;r (female) 
WT1creERT21+. Smofl+ , 
F2 (male) WT1CreERT21+;Smoflf (5/9, 55%) 
Smoflt (female) 
WT1creERT2!+;Smotlf (16/74, 22%; 3 carried 
WT1creERT21+;Smoflf (male) Rosa(tmRed)) 
F3 Smofl+; Rosa(tmRed) WT1creERT2!+;Smot1+ (14/74, 19%; 8 carried 
(female) Rosa(tmRed)) 
Smor;r and Smotl+ (44/74, 59%) , 
Note: both the Smo gene and Rosa locus are located on mouse chromosome 5. 
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Figure 18. Mesothelial loss-of-Hh function prevents the appearance of 
mesothelium-derived cells in the lung parenchyma. 
A 
B 
c 
"' 
"' t: 
"' 0.8 5 
~ O.fi 
0 
"-OJ 0 .4 
1:: 
~ 0.2 
Ci 
0:: 
.o 
.. 1 
01 
t: 
~ 0.8 
u 
J? 0.6 
.1: 
"' 0.4 1:: 
(i 0.2 
~ 
D Control 
Glil 
Mutant 
Lungs from WT1creERT2!+;Smoflf,Rosa(tmRed) embryos (Mutant) and 
WT1creERT2I+;Smor1+,Rosa(tmRed) littermates (Control) were collected at E14.5 
after 2 doses of TAM at E10.5 and E11.5. (A,B) qRT-PCR analysis for G/i1 and 
Ptc1 mRNA expression in control and mutant lungs. Results were normalized to 
18s RNA. Results represent mean ± SEM from 3 mice. *p<0.05. (C) 
Quantification of tmRed+ cells in the lung parenchyma of mesothelial loss-of-Hh 
signaling mutant lungs compared to controls. The number of tmRed+ cells in the 
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lung parenchyma was normalized to the area size. Data represented are an 
average .±. SEM number of tmRed+ cells per unit area from a total of 30 lung 
sections, 10 sections per embryo. *p<0.05. (D) Representative images of the 
lung and heart from mesothelial loss-of-Hh function mutant and control embryos 
at E14.5. TmRed+ cells were visualized by fluorescent microscopy. * marks 
tmRed+ cells in the parenchyma of a control lung. 
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Figure 19. Examination of the lung phenotype in mesothelial loss-of-Hh 
function mutant lungs 
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Lungs from WT1creERT2!+;Smorlf (mutant) and WT1creERT2I+;Smof1+ littermate 
controls were analyzed at E14.5 and E18.5 after TAM administration at E10.5 
and E11.5. (A) Mesothelial loss-of-Hh function mutant lungs exhibited reduced 
mRNA expression of smooth muscle specific genes including Smoothelin, Myocd 
(myocardin) , Smooth muscle actin (SMA) , and SMA alpha2 without any change 
in expression of the epithelium-specific transcription factor Nkx2. 1. Results were 
normalized to 18s RNA. Data represent mean ± SEM from 3 mice. *p<0.05. (B) 
Mice with mesothelial loss-of-Hh function had reduced lung size at E18.5. Left 
lobes of mutant and control lungs were shown. 
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To test whether deficient Hh signaling in mutant lungs alters proliferation and/or 
apoptosis of mesothelial lineages, leading to reduced number of tmRed+ lung 
parenchymal cells, we performed Ki67 and activated Caspase 3 immunostaining 
in E14.5 mutant and control lungs. We did not detect any difference in the 
percentages of surface or parenchymal tmRed+ cells that were Ki67+ (Fig . 20A-
C). In addition, we did not observe apoptosis in lungs of both genotypes at this 
developmental stage (Fig. 21: fetal liver served as positive control). Finally, to 
determine whether loss-of-Hh function in the visceral mesothelium affected 
expression of EMT -related genes, we performed Snail 2 immunohistochemistry 
and found no difference between control and mutant lungs (Fig. 20D,E). 
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Figure 20. Mesothelial Loss-of-Hh function has no effect on cell 
proliferation or Snail2 expression in mesothelial cells and mesothelium-
derived lineages in lung parenchyma 
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Lungs were dissected from E14.5 WT1creERT2f+;Smo'1~Rosa(tmRed) embryos 
(Mutant) and WT1creERT2f+;Smo'1+;Rosa(tmRed) littermates (control) after 2 doses 
of TAM (E10.5 and E11 .5) . Immunohistochemistry for Ki67 and Snail2 was 
performed on lung sections collected from both mutant and control embryos. (A) 
Ki67 immunolabeling of lung sections from mutant and control embryos. 
Arrowheads mark tmRed+ mesothelial cells that were also Ki67+. White arrows 
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point to tmRed+ mesothelial cells that were Ki6T. (8, C) The percentages of 
Ki67+tmRed+ cells within tmRed+ populations in the mesothelium and the lung 
parenchyma of control and mutant embryos were quantified . (D) Double staining 
for Snail2 and WT1 in the mesothelium of mutant and control lungs. Arrowheads 
point to Snail2+wr1 + cells . (E) Quantification of the percentages of Snail2+wr1 + 
cells in the lung mesothelium of control and mutant embryos. Nuclei were 
counterstained with DAPI. Results represent mean± SEM from 3 mice. 
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Figure 21. Loss of Hh-function in mesothelial cells does not lead to 
apoptosis. 
Lungs were dissected from E14.5 WT1creERT2I+;Smo'1~Rosa(tmRed) embryos 
(loss-of-Hh function) and WT1creERT2I+;Smo'1+;Rosa(tmRed) littermates (control) 
after 2 doses of TAM (E1 0.5 and E11.5) to examine the effect of Hh loss of 
function in mesothelial cell apoptosis. The apoptosis marker Cleaved Caspase-3, 
was not detected in visceral mesothelium or in lung parenchyma of both mutant 
and control lungs at E14.5. (C) E13.5 wild type mouse liver section was used as 
a positive control for immunofluorescence analysis (arrows). 
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4.1.2 DISCUSSION 
In this study, we employed a rigorous WT1creERT2!+ lineage tracing system whose 
fidelity was confirmed to identify fetal mesothelium-derived progenies. We 
showed that fetal WT1+ mesothelial cells give rise to BSM, VSMCs, and desmin+ 
fibroblasts during embryonic and post-natal lung development. Of these cells 
types , only BSM was found to emerge during the embryonic period whereas 
others were identified after birth, suggesting different kinetics for mesothelial 
progenitor differentiation between lineages. Considering that mesothelial cell 
entry spans over several days of gestation, one possibility is that mesothelial 
cells that enter the lung early give rise to BSM, whereas cells that migrate at later 
time points, become VSMCs and fibroblast cells . Alternatively, all Wf1 + fetal 
mesothelial cells possess a similar capacity of differentiation, and their fate is 
determined by the environmental signals encountered after they enter the lung. 
The uniformly high efficiency of ere-recombination in our system and the 
fact that only subpopulations of differentiated cells were found to be tmRed+ 
suggest multiple origins for the mesenchymal lineages of the lung. In this 
context, the primitive fetal lung mesenchyme, including Tbx+ progenitors have 
been shown to give rise to smooth muscle (Grief et al. , 2012). Whether 
mesothelial and non-mesothelial progenitors have distinct and specialized roles 
in the development and maturation of airways, vessels, and interstitium is a 
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fundamental issue that will need to be addressed. Another key question relates 
to whether differentiated mesenchymal progenies with different fetal origins have 
discrete functional roles in homeostasis and tissue repair in post-natal life. 
Using a non-inducible WT1-Cre transgenic mouse only VSMCs were 
found to arise from the surface mesothelium (Que et al., 2008). In contrast, we 
employed an inducible Cre that was knocked into the WT1 locus: thereby 
supporting rigorous lineage tracing. Further, a recent lineage tracing study using 
a mesothelin knock-in Cre system found that VSMCs and fibroblasts in many 
tissues, including lung, arise from the overlying mesothelium (Rinkevich et al. , 
2012). We, however, did not observe mesothelin expression in the early fetal 
lung mesothelium, though we did observe expression in the fetal heart 
mesothelium; this expression pattern is in agreement with gene paint analysis 
(genepaint.org, Visel et al., 2004). These data argue that mesothelin is not a 
general marker for the early lung mesothelium. Thus, mesothelin+ mesothelial 
cells may represent a subset of progenitors whose contribution to lung 
development follows a time course that is different from what we observed with 
WT1 + progenitors. 
Using complementary in vivo and in vitro assays and live imaging, we 
found that WT1 + mesothelial cell entry into the underlying fetal lung requires the 
direct action of the Hh signaling pathway. Most notably, Hh signaling was not 
required for entry of mesothelial cells into the developing fetal heart, which is 
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consistent with previous results showing that the canonical Wntlj3-caten in 
signaling pathway is a key signal mediating movement of the heart's mesothelial 
cells (Von Gise et al., 2011 ). Our data suggest that lung epithelium-derived Shh 
ligand acts as a paracrine signal to activate Hh signaling in the overlying 
mesothelium. Interestingly, recent work shows that filopodia can deliver Shh 
ligand to targets over long tissue range (Sanders et al., 2013) . In this context, it is 
important to note that the timing of Shh airway epithelial expression coincides 
with WT1+ mesothelial cell entry (Bellusci et al. , 1997). We confirmed the 
essential role of this pathway through the targeted disruption of mesothelial Smo 
function . In these mice, we demonstrated significantly reduced mesothelial cell 
migration into the fetal lung parenchyma without any accompanying change in 
the gross morphology of the overlying mesothelium, cell proliferation, expression 
of EMT-related genes, or apoptosis. It is possible that the tmRed+ cells found in 
the mutant lung parenchyma is due to incomplete excision of the floxed Smo 
alleles. Further we did not observe cells accumulating in the mesothelium, 
suggesting that loss-of-Hh function mesothelial cells are sloughed from the 
surface. 
Based on our data, we propose 2 models for how Hh pathway activation 
controls mesothelial cell migration into the underlying fetal lung parenchyma. In 
the first model , Shh acts as direct chemo-attractant. This model is consistent with 
accumulated studies showing that Shh is a chemo-attractant for multiple different 
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cell types, including neural progenitors and macrophages (Charron et al., 2003; 
Dunaeva et al. , 2010; Polizio et al. , 2011). In the second model proposed , Shh 
induces a program that equips mesothelial cells with a facility for movement, 
which only then occurs following exposure to a second signal. In support of this 
second model, we did not detect any mesothelial cell movement during time 
lapsed imaging of cyclopamine treated lungs. Whatever the mechanism of Hh 
action, Wf1 expression was turned off in all cells after entry. 
Of interest, Hh pathway activation in fetal visceral mesothelium overlaps 
with Wf1 expression , raising the possibility of a regulatory interaction. 
Supporting this , Wf1 DNA binding sites have been identified within the 
promoter/enhancer regions of multiple Hh pathway genes, including Patched, 
Smoothed, and Gli (Hartwig et al. , 2010) . In a preliminary ChiP analysis of DNA 
isolated from early fetal mesothelial cells, we observed binding of Wf1 to the 
promoters of Patched and Smoothened. Together, these findings suggest that 
the distinct embryonic period of mesothelial migration reflects both the timing of 
Wf1 dependent induction of Hh pathway genes along with the availability of the 
Shh ligand. 
In conclusion, our study establishes that multiple lung mesenchymal 
lineages arise from the fetal mesothelium during distinct developmental periods. 
We also were able to demonstrate that during this process, active Hh signaling in 
the mesothelium is required for cells to enter the underlying parenchyma 
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whereupon they likely encounter additional signals that control their fate . The 
degree to which single mesothelial cells are multi-potent, however, or hard-wired 
to assume single cell fates is an open question that will require further study. 
98 
4.2 WT1 regulates Hh pathway mediated mesothelial cell entry and EMT 
into the underlying parenchyma 
4.2.1 RESULTS 
4.2.1.1 WT1 is essential for Hh pathway and EMT -related gene expression 
in fetal lung mesothelial cells 
To identify the function of WT1 in Hh-pathway mediated mesothelial cell entry 
and EMT, we assessed whether Hh signaling activity is diminished in WTr'- lung 
mesothelium at E13.5, a time when Hh signaling is active and mesothelial cells 
initiate entry (Refer to Chapter 3, Figs. 10 and 14). For this, GFP+ mesothelial 
cells were isolated from E13.5 WT1creGFPI+ and WT1creGFP!CreGFP KO lungs by flow 
cytometry. Notably, GFP+ cells were present only in the overlying lung 
mesothelium of these embryos (Fig. 22A), thereby ensuring the purity of sorted 
cells (Fig. 228). Cells from 6 embryos were pooled to analyze the mRNA 
expression levels of Hh pathway genes Gli1 and Ptc1 , EMT-related genes Snai/2 
and Twist1 by qRT-PCR. WT1 mRNA was found only in the GFP+ mesothelial 
cell population of lung and heart and not in the GFP- population (Fig. 23) 
ensuring the purity of the isolated mesothelial cells. Further, the expression of 
WT1 was significantly downregulated in WT1K0 lung and heart mesothelial cells 
compared to the littermate heterozygous controls. The mRNA expression of Hh 
pathway genes and EMT-related genes were significantly down regulated in the 
WT1K0 fetal lung mesothelium compared to the controls (Fig 22C) . The 
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expression of Gli1 and Ptc1 was not detected in epicardial cells (data not shown) , 
further supporting the idea that mesothelial cells lining different organs employ 
distinct signals for EMT and migration. 
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Figure 22. Hh pathway and EMT genes are down regulated in WT1"1- fetal 
lung mesothelial cells 
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Comparative gene expression analysis of isolated GFP+ WT1 +t- and WT1 _,_ lung 
mesothelial cells. (A) WT1 + mesothelial cells can be identified by their GFP 
expression on the lung surface of WT1CreGFPI+ mouse embryos at E13.5. (B) 
GFP+ mesothelial cells, denoted as CD45-; CD31-; GFP+ in P4 of the sort plot, 
were isolated by flow cytometry. (C) Expression of WT1, EMT genes Snai/2, 
Twist1 , and Shh pathway genes Gli1, Ptch1 was analyzed by qRT-PCR using 
total RNA isolated from a total of six WT1creGFP!CreGFP mutant embryos and 
littermate WT1creGFP+I- controls. 
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Figure 23. Characterization of GFP+ and GFP- isolated fetal lung and heart 
mesothelial cells 
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Characterization of GFP+ and GFP- isolated fetal lung and heart mesothelial 
cells_ Expression of WT1 was analyzed by qRT-PCR using total RNA isolated 
from a total of six WT1 c reGFP! CreGFP mutant embryos and littermate WT1creGF+I-
controls. 
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4.2.1.2 WT1 directly binds and regulates promoter elements of Hh pathway 
To identify the functional relationship between WT1 and the Hh pathway in 
isolated fetal mesothelial cells, we tested whether WT1 transcriptionally regulates 
Hh pathway genes Smoothened and Patched . By searching the conserved 
mammalian promoter sequences of Smo and Ptc1 genes, we found a single 
conserved WT1-binding site in the Smo promoter at 428 bp upstream of the 
transcription initation start site (Fig . 24A). Ptc1 promoter had three conserved 
WT1 binding sites (data not shown). 
To investigate whether Hh pathway constituents are controlled by WT1, 
we conducted chromatin immunoprecipitation assay on mesothelial cells isolated 
from E13.5 and E14.5 WT1creGFPI+ lungs (3000- 4000 GFP+ cells) by flow 
cytometry. Compared to DNA pull-down by lgG control , the WT1 antibody 
enriched for promoter sequences of Ptc1 , Smo and Sulf1 (positive control) by 3-5 
fold , as indicated by PCR using primers flanking predicted WT1 consensus sites 
(Fig. 248). These results suggest that WT1 directly activates Hh pathway genes 
in fetal lung mesothelial cells. 
To further examine, if WT1 directly stimulates Hh pathway constituents, 
we tested the activities of candidate WT1-binding site in transcriptional activity of 
Smo promoter in 293T cells. Wild-type Smo promoter sequence from position 2 
to 209, were cloned into a pGL3-firef/y /uciferase vector and the candidate WT1-
binding site was disrupted by converting essential G/C nucleotides into AfT (Fig. 
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24C). Transcriptional activities of wild-type and mutated Smo promoters were 
compared by a dual luciferase assay after transfecting 293T cells with the Smo-
firefly /uciferase construct, a TK-renilla luciferase construct (as a transfection 
control) and a pGL3-empty vector or WT1(-KTS). Transfection of the empty 
vector served to test the endogenous activity of WT1 in 293T cells. We found that 
the Smo promoter was activated 2-fold above the basal level by the 
overexpressed WT1 (-KTS) (Fig . 240) . Further, WT1 (+KTS) , a predominant 
RNA-binding form and had no effect on the Smo promoter (Fig . 240) , indicating 
that the WT1 (-KTS) isoform, directly regulates the transcription of Smoothened 
in lung mesothelial cells. 
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Figure 24. WT1 binds to the promoters of Smo and Ptc1 to regulate their 
transcription 
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WT1 binds to the promoters of Smo and Ptc1 to regulate their transcription . (A) 
Alignment of conserved WT1 binding sites in the Smoothened promoter region 
among species, Rat, Mouse and Human. (B) Three conserved amino acids 
containing the WT1 binding sites in the Smoothened promoter, were mutated 
from G to either AfT. (C) GFP+ cells were pooled from WT1creGFP for ChiP assay. 
The same amount of sonicated chromatin was used in the total input and for 
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immuno-precipitation with the lgG negative control and a WT1 antibody (Ab) prior 
to PCR. The WT1 antibody enriched Ptc1, Sulf1 and Smo promoter sequences 
by 3-5-fold in the pull down than lgG control. (D) Wild-type and mutated Smo 
promoter with a disrupted WT1-binding site was cloned into pGL3-Iuciferase 
vector and their transcriptional activities compared by dual luciferase assay in 
293T cells. Cells were co-transfected with an empty pGL3-vector (endogenous 
WT1) or WT1 (-KTS) or WT1 (+KTS), and the results were normalized to the 
basal activity of the pGL3- empty vector. Data shown represent mean ± standard 
error (SEM) with a p <0.05. (E) A model by which WT1 regulates Smoothened in 
lung mesothelial cells. WT1 activates mRNA expression of Smo by directly 
binding to its promoter, thereby mediating mesothelial cell entry into the lung 
parenchyma. 
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4.2.1.3 WT1 is required for lung development 
To examine the function of WT1 in the lung, we generated WTr1- embryos by 
mating heterozygous mice that carry one loss-of-function allele [knock-in GFP 
(WT1creGFP+I-) mouse x TAM-inducible Cre (WT1creERT2+1-)]. Consistent with 
previous reports, WT1+!- mice were grossly normal, however, more than half of 
WTr1- embryos in the C578U6 (86) background died around E13.5 and no 
viable embryos were found after E15.5 (Kriedberg et al. , 1993). The lungs of 
surviving WTr'- embryos were smaller than littermate controls and exhibited 
peripheral edema, small dysmorphic heart and lungs, reaffirming previous finding 
(Von Gise et al., 2011) (Fig . 25A). Examination of the lungs at E13.5 revealed 
incomplete separation of accessory lobes (Fig. 258) . The gene expression levels 
of of Hh pathway genes Gli1 and Ptc1, and EMT-related genes Snai/2, Twist1 
were significantly downregulated in WTr'- lungs compared to controls (Fig. 27). 
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Figure 25. Analysis of the WT1K0 embryos and lungs 
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(A) E13.5 WT1creGFP! CreERT2!- mutant and WT1creGFP control embryos were 
generated . The WT1_,_ embryos are much smaller than the littermate controls. (B) 
The WT1 ·'· embryo showed signs of cutaneous edema as indicated by asterisk. 
Lungs were 60% smaller than the controls {Lung was damaged during 
dissection}. Interestingly the right distal and accessory lobes were fused as 
indicated by black arrow. (C) WT1creGFPt CreERT21+ mutant mice were generated in a 
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C3H x 86 mixed background, after 5 rounds of outbreeding. WT1K0 embryos in a 
mixed background are smaller and paler than littermate controls. (D) Lungs from 
WT1 mutant mice are hypoplastic compared to heterozygous control mice. 
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In order to analyze the cell lineages derived from the mesothelium in late 
gestation, we generated mice with WT1 mutation in C3H background. The 
concept for this experiment was based on a previous study indicating that wr1 
mutation onto different mouse backgrounds delays embryonic lethality (Herzer et 
al. , 1999). For this , WT1 creGFP and WT1 creERT2 heterozygous mice were outbred 5 
generations in C3H background . wrr1- C3H X 86 mixed background embryos 
and lungs were significantly smaller than littermate controls at E16.5 (Fig . 25C, 
D). Expression of WT1 was significantly downregulated in multiple internal 
organs lined with mesothelial cells including lungs (Fig. 26A). Preliminary 
analysis of smooth muscle cells revealed decreased expression of smooth 
muscle actin in the distal lung compared to heterozygous littermate controls (Fig. 
268). Further, WTr'- lungs had a markedly diminished expression of Ki67 
(proliferation marker) and Snail2 (EMT-related gene) compared to wrt+t-
littermate controls (Fig. 26C, D). 
Together, these data support a paradigm where WT1 regulates EMT and 
proliferation in fetal lung mesothelial cells and further demonstrates a role of WT1 
in the derivation of smooth muscle lineage during lung development (Dixit et al. , 
2013) . 
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Figure 26. Loss-of-WT1 function diminishes proliferation, Snai/2 expression 
and smooth muscle in the distal lung 
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Lungs were dissected from E16.5 WT1creGFP!CreERT2!+ mutant mice (WTr1-) and 
WT1creERT2!+ littermates control (WT1+1-) . Immunohistochemistry for WT1 , SMA, 
Ki67 , and Snail2 was performed on lung sections collected from both mutant and 
control embryos. (A) Expression of WT1 is diminished in (WTr1-) mice compared 
to controls. Arrows point to positive WT1 expression in the lung visceral 
mesothelium of a control lung (see inset). (B) Expression of SMA is dramatically 
reduced in the distal lung. (C) Snail 2 EMT related gene expression is diminished 
in the lung parenchyma and in the visceral mesothelium (black arrows, inset 
shows positive cells). (D) Ki67 immunolabeling of lung sections from mutant and 
control embryos. Arrowheads mark mesothelial cells that are Ki67+ (as seen in 
inset). 
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Figure 27. Loss-of-WT1 function diminishes the expression of WT1, Hh 
pathway genes, and Snai/2 in embryonic lungs 
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Comparative gene expression analysis of Control (WT1+'-) and WT1K0 (WTr'-) 
lungs. (A) E13.5 WT1creGFP!CreERT2J- mutant and WT1creGFP control embryos were 
generated. Expression of WT1, EMT genes Snai/2, Twist1 , and Shh pathway 
genes Gli1, Ptch1 was analyzed by qRT-PCR using total RNA isolated from three 
WT1creGFP!CreGFP mutant embryos and littermate WT1creGFP+I- controls. 
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4.2.2 DISCUSSION 
Previously, we demonstrated that Hh pathway is required for WT1 + mesothelial 
cell entry into the fetal lung (Dixit et al. , 2013). Here, we have identified a direct 
interaction between WT1 and the Hh pathway in lung mesothelial cells. We show 
that WT1 acts upstream of the Hh pathway and that it also regulates EMT and 
proliferation in the lung mesothelium. Further, we found that WT1 is required for 
normal lung development and the derivation of smooth muscle in the distal lung. 
WT1 regulates EMT -related genes Snail, Snai/2, and E-cadherin m 
epicardial progenitors (Martinez-Estrada et al. , 2010; Von Gise et al. , 2011) . In 
support of this finding , we found that Snai/2 and Twist1 mRNA expression levels 
were down regulated in WT1K0 lung mesothelium compared to controls . 
Remarkably, the expression levels of Snai/2 and Ki67 were downregulated not 
only in WT1 K0 mesothelial cells but also in the lung parenchyma, indicating that 
WT1 does not directly control prol iferation and EMT gene expression in the lung 
parenchyma, instead, WT1 regulates other genes and pathways that mediate 
developmental processes in the lung. Future studies will clarify if WT1 directly 
binds and regulates EMT genes in lung mesothelial and mesenchymal cells. 
Previously, we illustrated that mesothelium-restricted loss-of Hh function 
leads to hypoplastic lungs in late gestation. However, we could not detect an 
observable difference in the smooth muscle distribution in the lungs of 
mesotheliai-Hh function mutants compared to controls (Dixit et al. , 2013) . In 
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contrast, preliminary data presented here shows that WT1 K0 lungs exhibit a 
hypoplastic phenotype with a significantly reduced expression of smooth muscle 
actin in the distal lung compared to littermate controls. The more severe lung 
phenotype in WTr1- as compared to mesothelial loss-of Hh function mice 
suggests that WT1 regulates multiple genes/pathways required for mesothelial 
lineage derivation, as shown in the schematic (Fig. 25). 
A hypoplastic lung phenotype has been observed 1n many conditions 
including broncho-pulmonary dysplasia, congenital diaphragmatic hernia and in 
mice with loss of Myod function (Warburton et al. , 2001; Smith et al. , 2005; 
lnanlou and Kablar, 2003) . Lungs in these mice are smaller than controls and 
have significantly reduced smooth muscle content around airways and not 
vessels. Further, they have reduced proliferation and cannot support fetal 
breathing movements or lung peristalsis, which is essential for smooth muscle 
formation in the lung (Harrison et al., 2003) . These findings indicate that 
hypoplastic lungs and reduced SMA expression may be a secondary effect due 
to defects in the diaphragm and not the lung itself. Future studies will need to 
confirm whether loss of WT1 function directly impacts smooth muscle formation 
in the lung. It is of interest to note that serum response factor (SRF) has several 
binding sites for WT1 (unpublished data). Genes that are expressed in the 
smooth muscle require SRF for gene transcription and SRF inturn interacts with 
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various cofactors and co-repressors to regulate smooth muscle formation in the 
lung and in other organs. 
In conclusion , our study establishes a direct interaction of WT1 and Hh 
pathway in mesothelial cells. Further, we showed that WT1 is required for normal 
lung development, in particular smooth muscle formation in the distal lung. The 
degree to which WT1 plays a role in lung development and normal function will 
need to be determined by future lineage studies. 
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Figure 28. Model describing the hierarchical relationship between WT1, Hh 
pathway and EMT in lung mesothelial cells 
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WT1 is upstream of Hh pathway and EMT in lung mesothelial cells. WT1 
regulates Hh pathway to prime mesothelial cells for entry, Thereafter, WT1 may 
directly control EMT genes to promote EMT and entry of mesothelial cells. Other, 
yet to be identified signals regulated by WT1, mediates differentiation of 
mesothelial cells in the lung parenchyma. WT1- Wilms tumor 1, Hh- Hedgehog, 
EMT- Epithelial mesenchymal transition 
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4.2.3 FUTURE WORK 
1) Generate a WT1_,_ KO (WT1creERT2!CreERT2) in a 86 and a C3H Rosa-
CAG'5tdTomato background, inject TAM at E10.5 and examine lungs at 
E13.5, E18.5 and postnatal day1. 
2) Characterize the phenotypes and examine the pattern of tmRed+ cells in the 
lung parenchyma and compare it to the littermate control (WT1creERT2!+,Rosa-
CAG'5tdTomato). Analyze the expression of SMA by western blot 
3) Test whether gain-of Hh function will (partially) rescue phenotypes of WTr1-
lungs. 
a) In vitro - we will breed WT1ff mice with WT1creERT2 mice in a tmRed 
background, inject TAM at E10.5, harvest lungs and E12.5 and test 
whether lung culture in the presence of SAG, Hh pathway agonist, will 
rescue the mesothelial cell entry phenotype. 
b) In vivo- we will generate WT1creERT2!CreERT2; Rosa(SmoM2);Rosa(tmRed) 
mice. SmoM2 contains a W539L point mutation and upon ere-mediated 
excision of a stop fragment in the Rosa(SmoM2) allele , Hh signaling is 
constitutively activated35. These mice will receive TAM injection at E10.5 
and the phenotypes of EMT and mesothelium-derived cell entry will be 
compared to those in TAM-treated WT1creERT2!CreERT2,Rosa(tmRed) mice 
and control WT1creERT2/+;Rosa(tmRed) mice at E12.5 and E13.5, using 
assays described. 
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Chapter 5 Role of mesothelial cells and their progeny in injury associated 
repair and remodeling process 
5.1 Summary 
Recent studies have demonstrated that cells arising from the mesothelium 
contribute to differentiated mesenchymal components of the heart, liver, and gut 
during organogenesis, and are involved in injury assoCiated remodeling and 
repair (Wilm et al. , 2005; Asahina et al., 2011; Zhou et al., 2008). The 
proposition that the lung mesothelium plays a similar role in wound healing post-
injury, is an open question, thus we have begun to clarify this issue. This chapter 
describes preliminary data generated to address to question. 
5.2 Introduction 
Adult lung progenitors, under homeostatic condition, proliferate relatively slowly 
compared to epithelial progenitors of the skin and small intestine (Kauffman 
1980; Rawlins & Hogan 2008). However, after exposure to trauma or injury, the 
cells become active and migrate to the site of injury, to replace damaged and 
dead cells (Desmouliere et al., 2005). Deregulation of this process can causes 
chronic inflammation and fibrosis (reviwed by Horowitz et al., 2012). Lung 
mesenchymal cells such as fibroblasts, smooth muscle cells and alveolar 
myofibroblasts are not only involved in closure of wounds but excess 
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parenchymal cells can lead to asthma, most common chronic disease in children 
(Wang et al. , 2008; Rocket al., 2011 ). 
World health organization (WHO) reports that chronic respiratory 
conditions, such as chronic obstructive pulmonary disease and pulmonary 
fibrosis, are the third leading cause of death worldwide. To date, a cure for these 
chronic diseases is not available, common treatment strategies only alleviate the 
symptoms. Lung transplant is not an available option to many patients, although 
recently developed bioengineered lung may pave the way for future organ 
transplantations (Ott et al. , 201 0). However, much work is needed before this 
technology can be used for mainstream clinical application. 
One other approach to repair the damaged tissue could be to manipulate 
endogenous mesenchymal and epithelial progenitor cells in the lung. Although, 
very little is known about the source of mesodermal cells, there is considerable 
literature on adult epithelial progenitors in the lung. Bronchiolar epithelial cells 
expressing p63 and Krt5 are capable of regenerating injured airway epithelium 
(Beers amd Morrisey 2011 ). Similarly, variant clara cells around neuroendocrine 
bodies replace ciliated and clara cells of the bronchiolar region after exposure to 
naphthalene induced injury (Hong et al., 2001 ). Another recent study analyzed 
compensatory lung growth after unilateral removal of the left lung and found that 
bronchiolar, alveolar epithelial and endothelial cells associated with pulmonary 
capillaries repopulate the lung after post pneumonectomy (Paxson et al., 2009). 
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Recent studies have shown that WT1 + mesothelial progenitors give rise to 
epicardium and serous layer and contribute to differentiated mesenchymal cells 
within internal organs (Zhou et al., 2008; Asahina et al., 2010). In the heart and 
liver, mesothelial cells undergo epithelial-to-mesenchymal transition after injury, 
and participate in reparative process of the injured tissue (Von Gise et al., 2011 ). 
In the lung, WT1 + mesothelial cells give rise to lung viscera and differentiated 
mesenchymal components (Dixit et al., 2013). However, the role of mesothelial 
cells and their progenitors in injury-associated repair and remodeling of the 
damaged lung tissue is not known and has not been examined. 
Using immunohistochemical techniques, we found that lung mesothelial 
cells reactivate the expression of WT1 and begin to proliferate three days post-
pneumonectomy, indicating that WT1 + mesothelial cells participate in lung 
regeneration after compensatory lung growth. 
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5.3 Materials and methods 
Immunohistochemistry 
Paraffin sections of PBS-treated or ova-treated Asthmatic lungs were kindly 
provided by Dr. Xingbin Ai , Pulmonary Center, Boston University School of 
Medicine. 5 J.im tissue sections were blocked in MOM block (Vector Laboratories) 
for 1 hour. High pH antigen retrieval (Vector Laboratories) was used before 
staining with anti-WT1 (1 :200, Dako) primary antibodies, anti-PCNA (Invitrogen). 
Antigen-antibody complex was visualized by DAB. 
RT-PCR 
Tissues of snap-frozen PBS treated or ova-treated Asthmatic lungs were kindly 
provided by Dr. Xingbin Ai, Pulmonary Center, Boston University School of 
Medicine and tissues of snap-frozen PBS treated or Bleomycin-treated Fibrotic 
lungs were kindly provided by Dr. Jining Lu, Pulmonary Center, Boston University 
School of Medicine. Total RNA was isolated using an RNeasy mini kit (Qiagen) . 
eDNA was transcribed using the GoScript reverse transcription system 
(Promega). All taqman probes for 18sRNA and WT1 were obtained from Applied 
Biosystems. Quantitative real time PCR (qRT-PCR) was performed using a Step 
One plus instrument (Applied Biosystems). Assays were performed in triplicate 
and either normalized to 18s RNA (Taqman). Relative gene expression was 
calculated by the T~l.t.CT method (according to manufacturer's protocol). See 
supplementary material Table 5 for Taqman primer details. 
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5.4 Experimental design 
Previously we showed that fetal mesothelial cells g1ve rise to a distinct sub-
population of BSM, VSM, and desmin+ fibroblasts (Dixit et al. , 2013). In order to 
examine the contribution of fetal mesothelial cells and their progenies to overall 
repair and remodeling in the post-natal lung, we studied three relevant cond itions 
of disease. 1) ovalbumin-mediated allergic asthma model to examine if excess 
BSM are derived from mesothelial or mesothelial derived cells, 2) a fibrotic 
process where there is increase in myofibroblasts and fibroblasts , as seen in 
bleomycin-induced model of fibrosis and , 3) a model of compensatory lung 
growth and regeneration post-pneumonectomy (Fig. 28) . 
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Figure 29 Role ofWT1+ mesothelial cells in lung injury 
WTl regulated mesothelial program 
WTl+ 
~#~~~ 
;p-#· \ I ~, 
Hh pathway 
mediated entry VWTl-
85! I \\the~ 
VSM Desmin+ 
fibroblasts 
Lung Injury 
} Mesothelium 
lung 
Parenchyma 
Remodeling of inflammation-associated 
lung injuries and re-growth 
Remodeling of non-inflammatory 
lung regeneration model 
! ! ! 
Neonatal and adult Bleomycin induced Pneumonectomy 
model of ova- pulmonary fibrosis 
induced asthma 
Schematic describing the role of WT1 + mesothelial cells in lung development and 
injury repair and remodeling 
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5.4.1 Neonatal and adult model of ovalbumin-induced asthma 
Asthma is a chronic inflammatory disease of the lung characterized by airflow 
obstruction, bronchial smooth muscle hypertrophy and hyperplasia, and airway 
hyperresponsiveness. One of the hallmark features of asthma is increase in the 
number of airway smooth muscle cells. To date, the origin of smooth muscle 
contributing to the pathology of asthma and the mechanism underlying excess 
BSM remains unknown. Ovalbumin-induced allergic asthma is a widely used 
model to reproduce the hallmark features of human asthma with elevated lgE 
levels (Bentley et al. , 2010). Ovalbumin (OVA) derived from chicken egg is a 
frequently used allergen that induces a robust, allergic response in mouse 
models. Here we examined whether WT1 + mesothelial cells potentially serve as 
a source of the increased smooth muscle cells in ovalbumin-mediated neonatal 
and adult acute asthma model in mice. 
Preliminary Data 
To examine if BSM derived from mesothelium leads to asthmatic phenotype, we 
first tested if WT1, a mesothelium specific marker, is reactivated in an adult lung 
after ovalbumin-mediated asthma. In th is context, previously we found that the 
expression of WT1 rapidly declines in late gestation and is undetectable in a 
postnatal and adult lung mesothelium (Dixit et al., 2013). Tissue samples were 
collected from mice that received OVA or PBS as neonates or as adults (see fig . 
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29 for protocol) and were confirmed to have a bronchial smooth muscle 
hyperplasia by our collaborators. qRT -PCR analysis on RNA extracted from 
these samples indicated that there was no significant difference in the WT1 
mRNA levels of ova-treated lungs versus pbs-control samples (Fig. 29), 
indicating that reactivation of the fetal mesothelium program does not occur in an 
asthmatic condition. 
Next, we examined whether WT1 reactivates in an adult acute model of 
asthma. As previously observed, we did not observe a significant difference in 
the expression of WT1 in Ova-treated lungs compared to controls, reiterating that 
fetal mesothelium program does not reactivate in an adult lung post-asthma 
induction. 
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Figure 30. WT1 is not upregulated in neonatal and adult ova-mediated 
allergic asthma 
A. Neonatal asthma model 
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(A) Schematic of a neonatal ova-mediated allergic asthma. (B) Lungs from ova-
treated and pbs-control mice were collected at P21 . qRT-PCR analysis for WT1 
mRNA expression in pbs and ova lungs. Results were normalized to 18s RNA. 
Results represent mean ± SEM from 3 mice. *p<0.05. (C) Schematic of an adult 
ova-mediated allergic asthma. (D) Lungs from ova-treated and pbs-treated 
control mice were collected on day 20 in adults . qRT-PCR analysis for WT1 
mRNA expression in pbs and ova lungs. Results were normalized to 18s RNA. 
(E) WT1 immunohistochemistry on ova and saline-treated adult lungs. Arrows 
point to WT1 + mesothelial cells. 
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Future Work 
Since the fetal mesothelium program does not reactivate in an asthmatic lung, 
we will examine to what degree fetal mesothelium-derived progenies contribute 
to overall repair/remodeling in a postnatal asthmatic lung. For this, five 
WT1creERT2I+;Rosa(tmRed) mice will receive 2 doses of TAM at E10.5 and E11.5, 
in order to fluorescently label a significant proportion of mesothelial cells (refer to 
chapter 3). Thereafter, the mice will be subjected to asthma induction , as 
neonates as per established protocols (see fig. 29). Asthmatic and PBS-treated 
control mice will be sacrificed at day one post the last ova sensitization treatment 
and one day post-challenge. For each mouse, 10 lung sections will be collected 
and immunostained with the SMA antibody to identify BSM cells that are derived 
from WT1 + lung mesothelium. To quantify the number of mesothelium derived 
smooth muscle cells in asthma, ratio of tmRed+ SMA+ BSM cells to the total 
SMA+ BSM cells around small and medium sized airways will be compared and 
analyzed by Student's t test. 
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5.4.2 Bleomycin-induced fibrosis 
Pulmonary fibrosis is an interstitial lung disease characterized by thickening of 
alveolar walls, fibroblast hyperplasia, loss of basement membrane, deposition of 
extracellular matrix proteins, leading to scarring of the lung (Ohta et al., 1995). 
Bleomycin-induced fibrosis is a widely used model to investigate distal lung 
mesenchymal remodeling that occurs post-fibrosis in the lung (Thannickal et al., 
2004). Increases in fibroblasts and myofibroblasts are readily apparent at 7-10 
days post injury (Cushing et al., 2011 ). To date, the precise origin of these cells 
remains unknown. 
Preliminary Data 
To examine whether WT1 + mesothelial cells potentially serve as a source of the 
increased myofibroblasts and fibroblasts during a fibrotic process, we first tested 
if the expression of WT1 reactivates at multiple time points during the tissue 
remodeling and regeneration phase post-bleomycin induced injury. Briefly, the 
mice received intra-peritoneal bleomycin on day 0, 3, 7, 10, and 14 and the lungs 
were harvested on days 3, 7, 10, 28, and 70 (Fig. 30) (Cushing et al. , 2011 ). 
Typical subpleural fibrosis with macrophage infiltration and increased collagen 
deposition was observed at day 7. The fibrosis was progressed at day 10 and 
was at its peak with many fibrotic scars and lesions on day 28. Partial resolution 
of the fibrosis was observed at day 70. qRT-PCR for WT1 mRNA was conducted 
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on tissue samples collected from various time points after bleomycin injury. 
There was no significant difference in WT1 mRNA levels of a bleomycin-injured 
lung compared to pbs controls , indicating that reactivation of the fetal 
mesothelium program does not occur in a bleomycin-induced fibrotic condition . 
130 
Figure. 31 No significant difference in WT1 expression in a bleomycin-
mediated fibrotic lung compared to controls 
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Top panel: Schematic of bleomycin-induced fibrosis . Bottom panel : Lungs from 
belomycin-treated and pbs-treated control mice were collected on day 7, 28 and 
70. qRT-PCR analysis for WT1 mRNA expression in pbs and bleomycin-treated 
lungs. Results were normalized to 18s RNA. Results represent mean ± SEM 
from 3 mice 
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Future Work 
For future experiments, we will examine if the relative contribution of 
mesothelium-derived desmin+ myofibroblast lead to hyperplasia in a fibrotic lung. 
For this , five WT1creERT2!+;Rosa(tmRed) mice will receive 2 doses of TAM at 
E1 0.5 and E11 .5 so that a significant proportion of mesothelium-derived cells will 
be tmRed+ as previously described (refer to chapter 3). Subsequently, the mice 
will receive intra-peritoneal bleomycin on day 0, 3, 7, 10, and 14 and the lungs 
will be harvested on days 3, 7, 10, 28, and 70 (Fig . 30) (Cushing et al., 2011) . 
For each mouse, 10 lung sections will be collected and immunostained with 
desmin and SMA antibody to identify fibroblasts derived from WT1 + lung 
mesothelium. For quantification, ratio of tmRed+ SMA+ or desmin+ cells to 
desmin+ or SMA+ cells alone, will be compared and analyzed by Student's t test. 
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5.4.3 Pneumonectomy 
Healthy adult lung regenerates under normal condition when subjected to lung 
resection (Wansleeben et al. , 2013). However, the mechanisms underlying the 
regenerative processes are not well known . Pneumonectomy or surgical removal 
of a lung ; is one of the best models to understand the lung regeneration , since 
lungs regenerate over a short period-of time. Following this procedure, 
compensatory lung growth from the remaining lung lobes has been observed 
(Hsia, 2004). A thirty-year follow up study on children, adolescents and adults 
who underwent pneumonectomy revealed that the quality of life improved after 
the surgical procedure (Laros and Westermann, 1987). 
In mice, it has been demonstrated that, after surgical removal of the left 
lung under anesthesia, the remaining right lung sufficiently grows such that there 
is nearly 100% recovery of total lung capacity within two weeks (Voswinckel et 
al., 2004). Biological processes such as cell proliferation peaks between 3-7 days 
after pneumonectomy. Lung volume, DNA and protein content, including 
functional alveoli are restored within two weeks after surgery (Paxson et al., 
2009). 
Despite much information learned from this model, the precise origins of 
cells that reconstitute the various lung compartments remain largely unknown. 
Most recently, it was shown that VEGF signaling in the endothelium is required 
for successful lung regeneration in this model. Interestingly, WT1 directly binds 
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VEGF and regulates glomerular filtration in the kidney and tumor cell growth and 
metastasis (McCarty et al., 2011 ). Most notably, published work indicates that 
mesothelium-specific genes are markedly induced in the regenerating lung 
starting from day 3 post-pneumonectomy (Wada et al. , 2010). 
Preliminary Data 
To examine the relative contribution of the mesothelium to lung re-growth after 
pneumonectomy, we first tested if mesothelial cells lining the lung proliferate after 
the procedure. Remarkably, our collaborators (Dr. Andrew Hoffman- Tuft's 
University) have observed that pleural mesothelial cells retain BrdU labeling 3 
days post pneumonectomy (Fig . 31C) , suggesting a role for mesothelial cells in 
the regenerative process. Interestingly, sham control mice did not exhibit BrdU 
mesothelial labeling, indicating the proliferation was not due to the surgery 
procedure itself (thoracotomy- sham surgery without removal of the lung) . 
Indeed, we found a dramatic increase in mesothelial cell proliferation 1n 
the remaining lung after contralateral lung removal , as demonstrated by PCNA 
staining (Fig. 31 A , B). Further, the expression of WT1 was stimulated in the 
mesothelium at day 3 post-pneumonectomy and not in the sham control adult 
lungs, suggesting reactivation of the fetal mesothelial program (Fig. 31 D). Taken 
together, these findings lead us to speculate that cells arising from the overlying 
mesothelium contribute to lung regeneration following pneumonectomy. 
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Figure 32. Reactivation of WT1 post-pneumonectomy 
(A) Pneumonectomy activates WT1 expression and cell proliferation in adult lung 
mesothelium. No cell proliferation was found in sham-operated mice. (8, C) At 
day 3 post-pneumonectomy, mesothelial cells enter the cell cycle, as shown by 
immuno-labeling of a proliferative marker PCNA and BrdU labeling (data from Dr. 
Andrew Hoffman). (D) WT1 expression is re-activated in regions of mesothelium 
post-pneumonectomy, (E) whereas other regions remain WT1 negative. 
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Future Work 
We have generated WT1CreERT21+; Rosa-CAG'5 tdTomato mice, that will be 
transferred to Dr. Hoffman's mouse facility where TAM injection and 
pneumonectomy will be performed. Fifteen animals will be divided into three 
groups, 5 mice/group be and used for the experiment. 
Group 1) Tamoxifen treated, No surgery- endpoint 10 days, (to examine the 
effect of Tamoxifen) 
Group 2) Tamoxifen treated Sham-operated -endpoint 10 days, Tamoxifen will 
be injected Day 3 and 5 post-surgery 
Group 3) Tamoxifen treated pneumonectomy- endpoint 10 days, Tamoxifen will 
be injected Day 3 and 5 post-pneumonectomy 
To identify the mesothelium-derived tmRed+ cell types in the lung parenchyma, 
immunohistochemistry will be performed on lung tissue based on morphology 
and location. 
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Chapter 6 WT1 + mesothelial cells in the hilar region are a source of stem/ 
progenitor cells 
6.1 Introduction 
Long-lived stem cells can both divide to self-renew and differentiate to replace 
lost tissue during normal homeostasis and wound repair. These cells have 
enormous potential to regenerate and aid in recovery from a variety of injuries 
and possibly debilitating diseases (Wansleeben et al., 2013). Although many 
epithelial progenitor cells have been discovered, the origin of lung stem cells 
remains an open question. 
A recent study has discovered a novel stem cell niche in the hilar region of 
the ovary and showed that ovarian carcinoma originates from mutated hilar cells 
(Fiesken-Nikitin et al., 2013). Hilum is the region of an organ that permits 
arteries, veins, nerves, bronchi , and other structures to enter and exit. It is also 
an area, which tightly anchors lungs, heart, and trachea near the root of the lung. 
The hilum of the lung is the point where the parietal pleura (mesothelial cells 
lining body wall cavity) and the visceral pleura (mesothelial cells lining the lung 
surface) meet. 
As previously discussed (in section 1.28), mesothelial cells lining adult 
lungs are highly susceptible to damage from air, water, and foreign substances, 
which causes them to slough from the surface into the fluid-filled pleural space 
137 
(Herrick and Mutsaers 2004). Since, adult lung mesothelial cells do not 
proliferate under steady state condition (Dixit et al. , 2013; Fig. 31A), the identity 
of the cells that replace the adult lung parietal and visceral mesothelium, after 
injury, is an open question . The proposition that the hilar cells of the lung migrate 
onto the lung surface and into the parenchyma, to repair and repopulate injured 
tissue, including pleural surface, is not known and has not been examined. We 
therefore have embarked upon identifying the fate of hilum cells near the root of 
the lung. 
6.2 Preliminary Data 
To examine whether cells in the hilum are a source of progenitors or stem cells, 
we first examined if WT1 is expressed in the hilar region. As shown in Fig. (32) , a 
group of WT1 + cells, identical to the ovarian hilum, are WT1 + in the lung hilum 
region. Future experiments will determine if WT1 + lung hilar cells are a source of 
stem or progenitors required for injury-associated remodeling and repair. 
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Figure 33. WT1 is expressed in the hilum region of the lung 
WT1 immunohistochemistry on adult lung sections. A-Fluorescent image shown 
in black and white, B-red fluorescence , nuclei were counterstained with DAPI 
(Blue) . WT1 expression is detected in hi lum region near the lung (L) and trachea 
(T). Arrows point to WT1 +hilum cells. Inset shows higher power image. 
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6.3 Future Work 
To determine if the WT1 + hilum cells are progenitor/ stem cells , we will use the 
already generated WT1CreERT21+; Rosa-CAG'5 tdTomato mice. Three doses of 
TAM and BrdU (1mg/day) will be administered and the animals will be sacrificed 
at 1 week, 1 month and 3 months of age. Intact lungs, heart, and hilar region , 
visceral mesothelium , and pleuropericardial region , will be examined for BrdU+, 
tmRed+ cells. 
Based on this data, future experiments will be designed accordingly to 
address, if the cells migrate into the lung parenchyma to give rise to lung 
mesenchymal and epithelial cell types. In the future , the function of these WT1 + 
hilum cells post-injury and after pneumonectomy will be examined . 
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